[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @AponiaAnalytics aponia_analytics aponia_analytics posts on X about $lly, $nvo, $azn, $sny the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::1816152863069925376/interactions)  - X Week XXXXXXX +127% - X Month XXXXXXX +32% - X Months XXXXXXX +604% ### Mentions: XXX [#](/creator/twitter::1816152863069925376/posts_active)  - X Week XXX +38% - X Month XXXXX +7.60% - X Months XXXXX +440% ### Followers: XXXXX [#](/creator/twitter::1816152863069925376/followers)  - X Week XXXXX +0.53% - X Month XXXXX +1.80% - X Months XXXXX +109% ### CreatorRank: XXXXXXX [#](/creator/twitter::1816152863069925376/influencer_rank)  ### Social Influence [#](/creator/twitter::1816152863069925376/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [currencies](/list/currencies) #1098 [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% [countries](/list/countries) XXXX% [technology brands](/list/technology-brands) XXXX% [social networks](/list/social-networks) XXXX% [exchanges](/list/exchanges) XXXX% [celebrities](/list/celebrities) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [$lly](/topic/$lly) #1, [$nvo](/topic/$nvo) #3, [$azn](/topic/$azn) #3, [$sny](/topic/$sny) #2, [$gsk](/topic/$gsk) #1, [$pfe](/topic/$pfe) #10, [pfe](/topic/pfe) #1, [$rhhby](/topic/$rhhby) #1, [$vktx](/topic/$vktx) #3, [$zldpf](/topic/$zldpf) #1 **Top accounts mentioned or mentioned by** [@icldc](/creator/undefined) [@cidrap](/creator/undefined) [@alphavestcap](/creator/undefined) [@glptrackerapp](/creator/undefined) [@thenci](/creator/undefined) [@thencis](/creator/undefined) [@varrell](/creator/undefined) [@elguapotron4000](/creator/undefined) [@fda](/creator/undefined) [@who](/creator/undefined) [@usfda](/creator/undefined) [@drmakaryfda](/creator/undefined) [@drsamuelbhume](/creator/undefined) [@ltbioinvestor](/creator/undefined) [@mrmikeinvesting](/creator/undefined) [@timopler](/creator/undefined) [@caitpollpoll](/creator/undefined) [@capitaljc](/creator/undefined) [@coachnickmoney](/creator/undefined) [@spartatrades](/creator/undefined) **Top assets mentioned** [Eli Lilly and Company (LLY)](/topic/$lly) [Novo-Nordisk (NVO)](/topic/$nvo) [AstraZeneca PLC (AZN)](/topic/$azn) [Synthetify (SNY)](/topic/$sny) [GSK plc (GSK)](/topic/$gsk) [Pfizer, Inc. (PFE)](/topic/$pfe) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [Sanofi (SNY)](/topic/sanofi) [Coop Coin (COOP)](/topic/$coop) [Viking Holdings Ltd (VIK)](/topic/$vik) [Bitcoin Incognito (XBI)](/topic/$xbi) [SPDR S&P XXX ETF Trust (SPY)](/topic/$spy) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [SuperRare (RARE)](/topic/$rare) [MicroCloud Hologram Inc. (HOLO)](/topic/$holo) [LM Funding America, Inc. (LMFA)](/topic/$lmfa) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [ritestream (RITE)](/topic/$rite) [Biogen Inc (BIIB)](/topic/$biib) [Eos Energy Enterprises, Inc. (EOSE)](/topic/$eose) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Oscar Health, Inc. (OSCR)](/topic/$oscr) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) ### Top Social Posts [#](/creator/twitter::1816152863069925376/posts) --- Top posts by engagements in the last XX hours "Type X Diabetes Market Exclusive Report with Detailed Study $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946241528172564667) 2025-07-18 16:11:54 UTC 4966 followers, XXX engagements "Sanofi completes $XXX billion acquisition of Blueprint Medicines Nasdaq delisting follows $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239744666399099) 2025-07-18 16:04:49 UTC 4964 followers, XXX engagements "🦉 G2 participants had higher baseline glucose (median XXXX mmol/L) and A1c (7.6%) than G1 (5.5 mmol/L 5.9%). Despite this they achieved larger absolute reductions over the study period. #diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947022266060972068) 2025-07-20 19:54:16 UTC 4963 followers, XX engagements "Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945887770754355362) 2025-07-17 16:46:12 UTC 4965 followers, XXX engagements "💼Tirzepatide plus hormone therapy boosts weight loss in menopausal women $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946333054378590266) 2025-07-18 22:15:35 UTC 4965 followers, XXX engagements "🦉 Contraindications: Personal/family history of MTC or MEN2 rules out GLP-1 RA use. No routine thyroid monitoring required. FDA cites theoretical cancer risk but no human trial evidence confirms it. #GLP1 #safety $NVO $LLY $AZN $SNY $VKTX $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947047198841098380) 2025-07-20 21:33:21 UTC 4954 followers, XXX engagements "$REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946654091578400825) 2025-07-19 19:31:17 UTC 4954 followers, XX engagements "Hims & Hers Health Inc. (HIMS) Alleged Deceptive $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240877967397321) 2025-07-18 16:09:19 UTC 4966 followers, XXX engagements "🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists GI side effectsprimarily nausea and diarrheawere the most frequent across agents. Gradual dose titration and combo therapy improved tolerability. #GLP1 $PFE $AZN"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946939177733329267) 2025-07-20 14:24:07 UTC 4962 followers, XX engagements "$LIXT $THTX $CLRB $OSTX $VRTX $ELAN $OGEN $NVS $FDMT $DYN $NKTR $IMAB $BCAB $INO"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1940802487495413768) 2025-07-03 15:59:06 UTC 4966 followers, XXX engagements "$MRK 💼Merck to Acquire Verona Pharma Expanding its Portfolio to Include Ohtuvayre (ensifentrine) a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943045207509139865) 2025-07-09 20:30:52 UTC 4967 followers, XXX engagements "💼Are GLP-1 drugs worth their current cost $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944819685976842737) 2025-07-14 18:02:00 UTC 4954 followers, XXX engagements "🦉 Bone mineral density (BMD) declines with rapid calorie restriction10% weight loss = XXX% lumbar/hip BMD loss. GLP-1RAs may mitigate this via enhanced Runx2 ALP Col1A1 expression in osteoblasts. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947025840509776054) 2025-07-20 20:08:29 UTC 4963 followers, XX engagements "🦉 Liraglutide reduced thigh muscle fat by XXXX% in XXXX% of patients vs. XXXX% in XXXX% on placebo. Z-score of muscle volume unchanged. MRI confirms structural remodeling without hypertrophy. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947025710305984751) 2025-07-20 20:07:57 UTC 4954 followers, XXX engagements "Hims & Hers Health Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy Triggers Securities Class Actions - HIMS Investors with Losses Encouraged to Contact Hagens Berman $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945887674344034429) 2025-07-17 16:45:49 UTC 4956 followers, XXX engagements "🦉 XX% of PCOS patients in a survey (n=1700) using GLP-1s reported more predictable periods; XX% had shorter bleeding days. Indicates hormonal impact beyond weight reduction. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946963310613557676) 2025-07-20 16:00:00 UTC 4964 followers, XXX engagements "💼Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GIP #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946217851292983547) 2025-07-18 14:37:49 UTC 4954 followers, XXX engagements "🦉 Liraglutide (Victoza Saxenda): daily injection. Semaglutide (Ozempic Wegovy Rybelsus): weekly or oral. Dulaglutide (Trulicity): weekly. All deliver durable GLP-1 signaling for metabolic control. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946956088219230341) 2025-07-20 15:31:18 UTC 4954 followers, XXX engagements "This week in X numbers: Nearly a quarter of companies offer GLP-1 drug coverage for weight management $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944171001279025452) 2025-07-12 23:04:22 UTC 4962 followers, XXX engagements "🦉 Predictors of success: HbA1c X% (aOR: XXX at X months; XXXX at XX months). Impairing factors: age XX (aOR: XXXX and 0.41) and primary care prescriptions (aOR: XXXX at X months). #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946994375692566954) 2025-07-20 18:03:27 UTC 4962 followers, XXX engagements "Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisks Weight Loss Drug Patent Expires $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944172361369935981) 2025-07-12 23:09:46 UTC 4964 followers, XXX engagements "Thermo Fisher and Sanofi Expand Strategic Partnership to Enable US Drug Manufacturing $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239905274720259) 2025-07-18 16:05:27 UTC 4966 followers, XXX engagements "Thermo Fisher acquires Sanofis steriles manufacturing site in US $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888522855985442) 2025-07-17 16:49:11 UTC 4964 followers, XXX engagements "Sanofi Into-Sana medical center network announce strategic partnership $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239659748602148) 2025-07-18 16:04:28 UTC 4966 followers, XXX engagements "Menopausal hormone therapy may boost weight loss seen with Zepbound $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945886176339984742) 2025-07-17 16:39:51 UTC 4960 followers, XXX engagements "🦉Tirzepatide cut apnea events by up to XX per hour and heart failure complications by 38%. GLP-1 drugs also lowered CRP IL-6 and TNF-key markers of systemic inflammation. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946219202664141220) 2025-07-18 14:43:11 UTC 4964 followers, XXX engagements "💼Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945932784213586115) 2025-07-17 19:45:04 UTC 4965 followers, XXX engagements "$QTTB 🌐 $SGN $FTFT $INKT $CVM $ZBAI $LMFA $HOLO $CAPR $FAAS $NVVE $SPY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943668966867505374) 2025-07-11 13:49:27 UTC 4965 followers, XXX engagements "Sanofi Appoints Rachid Ayari as Interim MD Inks Distribution Deal with Emcure $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIM"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890852846346626) 2025-07-17 16:58:26 UTC 4965 followers, XXX engagements "🦉 XXXX% of women on oral semaglutide lost XX% of body weight within X months; that proportion more than doubled to XXXX% at XX months. Median weight loss at XX months: XXX% XXX to XXXX. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946994205420646717) 2025-07-20 18:02:46 UTC 4963 followers, XX engagements "🦉 Eli Lilly is testing LY4065967 in a Phase X trial focused on how the drug behaves inside the bodyabsorption breakdown and elimination. It uses a radiolabeled version to track every move. Two dosing formats reveal how much actually gets used. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946006832423854403) 2025-07-18 00:39:18 UTC 4967 followers, XXX engagements "$CAPR 🌐 $SGN $FTFT $INKT $CVM $ZBAI $LMFA $HOLO $CAPR $FAAS $QTTB $SPY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943668673857613972) 2025-07-11 13:48:18 UTC 4965 followers, XXX engagements "How to sell Novo Nordisk tokenized stock (xStock) (NVOX) via a crypto wallet $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1940804565982761198) 2025-07-03 16:07:21 UTC 4963 followers, XXX engagements "🦉 Clinical trials: Liraglutide preserved cortical bone mass during weight loss. Systematic review (25 studies): GLP-1RAs increased BMD at lumbar spine/femoral neck in T2DM XX years. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947026211563016330) 2025-07-20 20:09:57 UTC 4954 followers, XXX engagements "GPs swamped by requests for NHS Mounjaro but hardly anyone qualifies $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946241330700496965) 2025-07-18 16:11:07 UTC 4964 followers, XXX engagements "🦉 Two-year data from over 51000 patients showed bariatric surgery led to XX% weight loss versus just XXX% for GLP-1 users. Even full-year GLP-1 adherence only reached X% far below trial results of 1521%. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944469331963998251) 2025-07-13 18:49:49 UTC 4965 followers, XXX engagements "🦉 Despite efficacy semaglutide discontinuation leads to weight regainSTEP X extension and STEP X confirm relapse within X year. Long-term therapy is necessary. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946983942386602290) 2025-07-20 17:21:59 UTC 4964 followers, XXX engagements "🦉 In the Swedish dataset semaglutide and liraglutide users also had fewer hospitalizations for substance use disorders and somatic conditionsexenatide did not replicate these results. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041838319219089) 2025-07-20 21:12:03 UTC 4954 followers, XXX engagements "💼Health Rounds: GLP-1 obesity drugs may boost low testosterone $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #testosterone"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945603323677061247) 2025-07-16 21:55:54 UTC 4962 followers, XXX engagements "💼Cancer Risk Concerns and Communication Gaps Regarding GLP-1 Medications $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946585925611294834) 2025-07-19 15:00:25 UTC 4964 followers, XXX engagements "🦉 GLP-1 boosts skeletal muscle glycogen synthesis through AMPK and PI3K/AKT signaling. But in T2DM defective AKT impairs this pathway. Exendin-4 increased glycogen synthase-a and GLUT4 in human myocytes. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947016444308226541) 2025-07-20 19:31:08 UTC 4962 followers, XX engagements "🦉 GLP-1 drugs reach deeper brain areas over time modulating hunger without activating all nausea circuits. Their impact depends on brain access vagal nerve input and how each person's biology responds to the signal. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945909789441098050) 2025-07-17 18:13:41 UTC 4964 followers, XXX engagements "💼Daniel Drucker Ozempics father: Im very conservative. I dont sell the drugs. I study the drugs The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However he remains cautious about their use $NVO"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946972586950221921) 2025-07-20 16:36:52 UTC 4963 followers, XX engagements "💼A new era of weight loss: Mental health effects of GLP-1 drugs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #psychology"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944468118140490048) 2025-07-13 18:45:00 UTC 4968 followers, XXX engagements "🦉 No difference in weight loss by sex: XXX% in women vs XXX% in men at XX months (p = 0.73). Similarly discontinuation (23.7% vs. 22.7%) and AEs (2.5% vs. 1.4%) were not sex dependent. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946994814714622182) 2025-07-20 18:05:11 UTC 4965 followers, XX engagements "Lillys orforglipron and other key catalysts set to reshape drug landscape $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944171883534201043) 2025-07-12 23:07:52 UTC 4962 followers, XXX engagements "Viking Therapeutics to Report Financial Results for Second Quart $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945886693099233575) 2025-07-17 16:41:55 UTC 4965 followers, XXX engagements "Fans Defend Serena Williams After Her New Gym Selfies Spark Ozempic Accusations $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS$NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945889577790500879) 2025-07-17 16:53:22 UTC 4952 followers, XXX engagements "🦉 XX trials included: STEP XX XX HFpEF HFpEF-DM. Intervention: semaglutide XXX mg weekly for 4468 weeks. Study populations ranged from XXX to 1900 participants. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946983089395179806) 2025-07-20 17:18:36 UTC 4954 followers, XXX engagements "🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists All six RCTs used treatment durations XX weeks. GLP-1 RAs showed sustained weight loss and metabolic improvements across diabetic and non-diabetic cohorts. #GLP1 #RCT $NVO $LLY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946938823163728174) 2025-07-20 14:22:42 UTC 4962 followers, XX engagements "🦉Semaglutide reduced major cardiovascular events by XX% kidney failure risk by XX% and resolved liver inflammation in XX% of MASH cases. Benefits occurred even with limited weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946219200797675872) 2025-07-18 14:43:11 UTC 4966 followers, XXX engagements "🦉 A non-peer-reviewed report falsely inflating mifepristones risk profile is reshaping political pressure on the FDA exposing biotech to arbitrary disruption and threatening investor confidence. #biotech #regulation"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946659392700494034) 2025-07-19 19:52:21 UTC 4963 followers, XX engagements "🦉 XX of XXX social media posts (10%) contained false claims. These included unproven uses underreported ADRs and complete absence of indication info. All platforms showed misinformation not just users. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946968768350990465) 2025-07-20 16:21:41 UTC 4964 followers, XX engagements "💼The Future of GLP-1s in Type X Diabetes with Viral Shah MD $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946284753394569310) 2025-07-18 19:03:40 UTC 4967 followers, XXX engagements "$BDPT 🌐 $NWBO $LWLG $GTCH $FNMA $NB $ELTP $RDGL $HMBL $COOP"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945536782478491992) 2025-07-16 17:31:29 UTC 4967 followers, 1089 engagements "🦉 Tirzepatide caused more GI issues in trials but delivered stronger weight loss while exenatide had higher nausea and injection site reactions. Liraglutide ranks worst for early nausea at 40%. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946587004810002651) 2025-07-19 15:04:42 UTC 4964 followers, XXX engagements "🦉 In the BELIEVE trial (n=507) bimagrumab + semaglutide achieved XXXX% total weight loss surpassing semaglutide alone (15.7%). Fat loss made up XXXX% of the drop minimizing lean mass lossa key advance in therapy. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944470805427183918) 2025-07-13 18:55:41 UTC 4964 followers, XXX engagements "🦉 Tirzepatide activates both GIP and GLP-1 receptors. Early data shows superior glucose and weight loss outcomes vs. semaglutide. Triple agonists targeting GLP-1/GIP/glucagon are under development. #Tirzepatide #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946956398970990661) 2025-07-20 15:32:32 UTC 4955 followers, XXX engagements "$APLS $ALPMY $OCUL $EYPT $REGN $SRZN $RHHBY $APLS $ALPMY 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943458677098451042) 2025-07-10 23:53:50 UTC 4967 followers, XXX engagements "💼The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945900485535322537) 2025-07-17 17:36:43 UTC 4963 followers, XXX engagements "Impact of Glucagon-Like Peptide-1 Receptor Agonists on Postoperative Outcomes in Arthroplasty: A Systematic Review $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240126570426730) 2025-07-18 16:06:20 UTC 4966 followers, XXX engagements "🦉 XX% increase in ankle-brachial index and improved walking distance in PAD patients treated with semaglutide (STRIDE trial). No quality of life change noted but perfusion and mobility metrics improved. #Semaglutide #PAD $NVO $LLY $AZN $SNY $VKTX $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947045602690314707) 2025-07-20 21:27:00 UTC 4954 followers, XXX engagements "💼The expanding benefits of GLP-1 medicines $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946219198885064995) 2025-07-18 14:43:10 UTC 4954 followers, XXX engagements "🦉 GLP-1 enhances hepatic glycogen synthesis via insulin-dependent and insulin-independent mechanisms involving AKT AMPK PI3K PKC and PP-1 signaling. GLP-1-deficient mice show reduced liver glycogen and glucose tolerance. #GLP1 #diabetes $NVO $LLY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947016323168358661) 2025-07-20 19:30:39 UTC 4955 followers, XX engagements "🦉 In postmenopausal women combining tirzepatide with hormone therapy led to a XX% weight drop3 points higher than with tirzepatide alone. Over XX% hit more than XX% total weight loss with the combo versus just XX% without. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946333056672895349) 2025-07-18 22:15:36 UTC 4968 followers, XXX engagements "$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945590268872270265) 2025-07-16 21:04:02 UTC 4965 followers, XXX engagements "Retrospective analyses indicate Ozempics protective effects against stroke fatality $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240078168096837) 2025-07-18 16:06:08 UTC 4966 followers, XXX engagements "🦉 Large-scale study (40k patients): semaglutide reduced periprosthetic infections sepsis and readmissions after knee arthroplasty. Yet increased MI AKI pneumonia also observed. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947034186604302561) 2025-07-20 20:41:38 UTC 4954 followers, XXX engagements "🦉 Bioimpedance: No significant change in VAT SAT or muscle mass in either group after X months. Despite weight loss and glycemic gains VAT reduction not statistically different. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947021840271995269) 2025-07-20 19:52:35 UTC 4954 followers, XXX engagements "$APGO $HMBL $DTREF $GTCH $SAPX $IGPK $ENTA $AFFU $TWOH $RITE $ADHC $FITY $CYBL $GTCH $NWBO $FNMA $ELTP $AVXL $PSRU $COOP $AFFU $CGAC $PSWW"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946261052397608995) 2025-07-18 17:29:29 UTC 4952 followers, XX engagements "🦉 Liraglutide and semaglutide delay gastric emptying. Tirzepatide mimics this but effect fades. Still dose-escalation preserved delay in T2DM patients unlike constant exposure. #Semaglutide #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947017128009208307) 2025-07-20 19:33:51 UTC 4954 followers, XX engagements "🦉 Use of SGLT2i lower in women than men (50.2% vs. XXXX% p 0.001). In women with CKD use was XXXX% vs. XXXX% in men (p = 0.04) suggesting a sex-based treatment gap in nephroprotection. #diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946995040040911349) 2025-07-20 18:06:05 UTC 4965 followers, XX engagements "🦉 In a 7-year cohort of 60860 adults with diabetes and obesity semaglutide and tirzepatide use was linked to a XX% lower dementia risk and XX% lower mortality. Stroke risk also dropped XX% with stronger effects in women and seniors. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946332187839672690) 2025-07-18 22:12:09 UTC 4968 followers, XXX engagements "🦉 XX% of participants in STEP trials reported GI disorders with XXX mg semaglutide weekly. Yet on Instagram these AEs were mentioned in X% of postsdespite being the most common reaction. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946967490187161998) 2025-07-20 16:16:37 UTC 4965 followers, XX engagements "🦉 In XXX men (avg. age 54) treated with semaglutide dulaglutide or tirzepatide for XX months normal testosterone rates rose from XX% to 77%. Greater weight loss was linked to larger hormonal gains. Drugs used: #Ozempic #Wegovy #Trulicity #Mounjaro #Zepbound"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946978920101765149) 2025-07-20 17:02:02 UTC 4955 followers, XXX engagements "💼GLP-1 receptor agonist therapy improves cardiometabolic outcomes in adults with overweight or obesity: A meta-analysis $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944482866127147025) 2025-07-13 19:43:36 UTC 4964 followers, XXX engagements "🦉 In the only randomized trial so far exenatide did not reduce heavy drinking overall. But in obese patients it significantly cut heavy drinking days and alcohol intake vs. placebo. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041293814665580) 2025-07-20 21:09:53 UTC 4954 followers, XXX engagements "🦉 Ozempic mentioned in XX% of posts; Wegovy in 18%; Rybelsusdespite FDA approvalonly 1%. Daily pill format and adherence challenges likely reduced its visibility. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946969241652994302) 2025-07-20 16:23:34 UTC 4954 followers, XXX engagements "🦉 The Mayo Clinic study tracked XXX women and showed the dual therapy may also help curb heart and metabolic risks. The effect was more than additive suggesting hormone therapy amplifies tirzepatides weight-loss action. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946333059046859101) 2025-07-18 22:15:37 UTC 4968 followers, XXX engagements "🦉 G2 (OB + T2D) patients lost more weight over X months than G1 (OB + PD): XXXX kg (p = 0.012) vs. XXX kg (p = 0.000). G1 plateaued after X months; G2 showed sustained reduction. #weightloss #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947021375778042274) 2025-07-20 19:50:44 UTC 4954 followers, XXX engagements "🦉 GLP-1 controls eating by acting on brainstem and hypothalamic circuits that sense gut signals and regulate fullness. These circuits reduce meal size delay gastric emptying and change food reward perception. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945909786827972991) 2025-07-17 18:13:41 UTC 4964 followers, XXX engagements "🦉 Recent findings confirm GLP-1 RAs not only reduce atherosclerosis but also restore mitochondrial dynamics by inhibiting Drp-1-driven fission and activating AMPK2. These changes reshape energy metabolism in diabetic hearts. #GLP1 #cardiovascular"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946296698659123663) 2025-07-18 19:51:08 UTC 4967 followers, XX engagements "🦉 Twelve percent of U.S. adults have used GLP-1 agonists like semaglutide or tirzepatide. A new 6-month University of Melbourne trial will use MRIs to evaluate brain changes in adults with BED taking GLP-1s. All subjects receive concurrent psychotherapy. GLP-1s are not yet approved for BED. #GLP1 #Tirzepatide $NVO $LLY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946977753703551471) 2025-07-20 16:57:24 UTC 4965 followers, XX engagements "🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists Liraglutide XXX mg/day (Jensen 2022) preserved appetite control and improved cognitive restraint and sedentary time over XX weeks. #liraglutide $NVO $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946938723704115222) 2025-07-20 14:22:18 UTC 4963 followers, XX engagements "$PRAX $NBIX $BHVN $XENE $AQST $BIIB $DNLI $JAZZ $UCBJF 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943458948419326040) 2025-07-10 23:54:55 UTC 4968 followers, XXX engagements "🦉 GLP-1 receptor agonists extend activity far beyond the natural hormones few-minute lifespan. Engineered to resist DPP-4 they remain active from several hours to X daysamplifying satiety and reducing caloric intake. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946954459482911081) 2025-07-20 15:24:50 UTC 4955 followers, XXX engagements "💼Which GLP-1 Has the Least Side Effects $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946587000976429324) 2025-07-19 15:04:41 UTC 4965 followers, XXX engagements "🦉 Brain scans showed weaker responses to high-fat high-sugar foods revealing tirzepatides unique action on both GLP-1 and GIP pathways. The effect outperformed liraglutide and didnt rely on willpower. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946333629124067710) 2025-07-18 22:17:52 UTC 4963 followers, XXX engagements "💼Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946332184404496838) 2025-07-18 22:12:08 UTC 4968 followers, XXX engagements "💼A sloppy report on mifepristone is being used to undermine the FDA and the biotech industry #biotech #regulation"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946659390506832059) 2025-07-19 19:52:20 UTC 4963 followers, XX engagements "🦉 Startups face direct liability as compounded GLP-1s bypass clinical trials lack consistency and trigger legal action over safety mislabeling and unfair competition. Investor trust is eroding fast. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945616354054185284) 2025-07-16 22:47:41 UTC 4968 followers, XXX engagements "Sanofi India appoints Rachid Ayari as Interim MD $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888892902645863) 2025-07-17 16:50:39 UTC 4964 followers, XXX engagements "💼The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945616349851496944) 2025-07-16 22:47:40 UTC 4968 followers, XXX engagements "🦉 Oral semaglutide reduced systolic BP by X mmHg after both X and XX months. In parallel XXXX% of women achieved HbA1c XXX% at XX monthsnearly identical to XXXX% in men. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946995301048299672) 2025-07-20 18:07:07 UTC 4962 followers, XXX engagements "$VKTX Viking is nearing key Phase X results for VK2735 its oral weight-loss drug tested in XXX adults with obesity-related conditions. Earlier data showed up to XXX% weight loss in just four weeks. If the 13-week results confirm strong and safe effects VKTX could gain ground in the massive obesity drug race"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943432430146257174) 2025-07-10 22:09:33 UTC 4962 followers, 1046 engagements "$EOSE 💼Industrial Services stocks outperformed the S&P XXX (+16.5% YoY vs 11.2%) trading at a premium 30.7x EV/EBITDA. Siemens grows software TAM by $11B via AI-driven acquisitions. Eos Energy eyes a XXX% revenue jump in 2025 on X GWh battery ramp-up. MSC Industrial targets IP Index +400bps with U.S. expansion. Sector backed by rising MRO e-commerce (18.9% global CAGR). #EosEnergy #Siemens $SIE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943292250357678242) 2025-07-10 12:52:31 UTC 4964 followers, XXX engagements "$NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945880380248117742) 2025-07-17 16:16:50 UTC 4956 followers, XXX engagements "🦉 GLP-1 recalibrates food perception by acting on the hypothalamus and reward centersdecreasing both physical hunger and hedonic craving. This dual effect makes it uniquely potent for weight regulation. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946955965229670865) 2025-07-20 15:30:49 UTC 4965 followers, XX engagements "🦉 Liraglutide preserved GLP-1R expression in osteoarthritic cartilage enhanced PKA/CREB signaling and decreased NF-B translocation. Mechanistic evidence for anti-catabolic cartilage effect. #GLP1 #arthritis $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947034382574747752) 2025-07-20 20:42:25 UTC 4954 followers, XXX engagements "💼Beyond a singular focus on GLP-1: why we need a new nomenclature now $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945880377148461579) 2025-07-17 16:16:49 UTC 4968 followers, XXX engagements "Novo Nordisk: Company Did Not Report or Investigate Deaths Potentially Caused by Ozempic $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888791463424394) 2025-07-17 16:50:15 UTC 4960 followers, XXX engagements "🦉 For weight loss CagriSema ranked highest with XXXXX kg followed by tirzepatide and retatrutide. Adverse events rose with dose notably GI issues making tolerability a key factor. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946592287380632026) 2025-07-19 15:25:41 UTC 4964 followers, XXX engagements "🦉 But they also experience more nausea anxiety and treatment dropout. Despite this females remain underrepresented in trials leaving gaps in understanding how these drugs work across sexes. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #sex"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945881961500660151) 2025-07-17 16:23:07 UTC 4956 followers, XXX engagements "💼Experimental flu drug may protect better than flu vaccines company data show #vaccine $CDTX #Cidara @CIDRAP"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1942734822029623440) 2025-07-08 23:57:30 UTC 4964 followers, 1011 engagements "$SRPT $RCKT $MBRX $DMAC $MAIA $AGEN $XXII $DNA $SDGR $PRAX $CYBN $NKGN $HROW $ALDX $BMY $RDNT $ACTU $TXG $IMAB $NLSP $KROS $AZN $JNJ $BCAB $SXTP $SXTP $OKYO $STXS $LSTA $CLSD $SRPT 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945886943696314875) 2025-07-17 16:42:54 UTC 4954 followers, 1475 engagements "🦉 PCOS affects XX million U.S. women. 3580% are insulin resistant. No standard treatment exists; birth control Metformin and lifestyle changes address symptoms partially. GLP-1s offer new metabolic leverage. #PCOS #GLP1 $NVO $LLY $AZN $SNY $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946964079089733922) 2025-07-20 16:03:03 UTC 4963 followers, XX engagements "$BULT $NWBO $HMBL $DTREF $GTCH $SAPX $IGPK $ENTA $AFFU $TWOH $RITE $ADHC $FITY $CYBL $GTCH $FNMA $ELTP $AVXL $PSRU $COOP $AFFU $CGAC $PSWW"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945893873311531280) 2025-07-17 17:10:27 UTC 4962 followers, XX engagements "🦉 YesGLP-1R agonists protect the brain after stroke reduce liver fat in NAFLD slow kidney disease and ease neurodegeneration. They also lower substance use and aid organ transplant survival. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945900488345432538) 2025-07-17 17:36:44 UTC 4964 followers, XXX engagements "$DWTX $TC $JG $TCTM $ONCO $NVNI $ETNB $HOLO $MLGO $HWH 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1940792154009518399) 2025-07-03 15:18:02 UTC 4966 followers, XXX engagements "Incretin-based approaches for type X diabetes therapy: effects on circulating cytokines and adipocyte's secretome $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239835523489795) 2025-07-18 16:05:10 UTC 4966 followers, XXX engagements "🦉 In a trial of XXX obese patients with knee OA semaglutide reduced both weight and pain. Liraglutide in contrast had no pain benefit despite weight loss. Drug-specific OA effects likely. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947034287414354186) 2025-07-20 20:42:02 UTC 4954 followers, XXX engagements "🦉 In Qeadan et al.s dataset of 800000+ adults with AUD GIP/GLP-1 agonists were associated with a XX% reduction in alcohol intoxication rates. This held true when stratified by both obesity and diabetes status. #GLP1 #Tirzepatide $NVO $LLY $AZN"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041089279451617) 2025-07-20 21:09:04 UTC 4954 followers, XX engagements "🦉 Tirzepatide led glycaemic control with a XXXX% HbA1c drop and XXXX mmol/L fasting glucose outperforming XX other GLP-1RAs. Its dose-efficacy was linear peaking at XX mg weekly. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946592284067192895) 2025-07-19 15:25:41 UTC 4965 followers, XXX engagements "Sanofi and EQT invest XXX million in SpliceBio to advance gene therapy $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944169057303032202) 2025-07-12 22:56:38 UTC 4965 followers, XXX engagements "🦉 Up to XX% of total weight loss from semaglutide and XX% from tirzepatide derives from lean body mass. Yet extremity muscle % remained stable and handgrip strength unchanged after X months. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947025585286287764) 2025-07-20 20:07:28 UTC 4954 followers, XXX engagements "🦉 Semaglutide was tied to fewer dementia cases while tirzepatide showed stronger results in stroke prevention and survival. Neither drug affected Parkinsons or brain bleeds pointing to a more targeted brain and vessel benefit. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946332190293233755) 2025-07-18 22:12:09 UTC 4968 followers, XXX engagements "Emcure Sanofi tie up for anti-diabetic range $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945886037240172925) 2025-07-17 16:39:18 UTC 4960 followers, XXX engagements "$NWBO NWBOs long-standing partnership with Cognate wasnt just strategicit was foundational. More than 2300 personalized DCVax-L doses were manufactured under full GMP making it one of the largest autologous immunotherapy trials ever run. When Charles River paid $875M to acquire Cognateover 11x revenueit effectively validated the manufacturing platform NWBO had quietly built. Add to that: DCVax-L lots remain viable after X years in cryostorage a rarity in cell therapy. Thats not typical. Thats moat"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1941837446896820588) 2025-07-06 12:31:39 UTC 4960 followers, 1524 engagements "🦉 Participants with no access issues lost more weight but those with just XX doses still dropped over 10%. Coaching and structured lifestyle changes helped soften the impact of missed meds. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946286547327726008) 2025-07-18 19:10:47 UTC 4967 followers, XXX engagements "🦉 Even without official approval more patients are trying GLP-1s for T1D. The spotlight is finally shifting from insulin alone to newer longer-acting and smarter treatments that could change the game. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946284757374963963) 2025-07-18 19:03:41 UTC 4968 followers, XXX engagements "$NCNA $HCTI $SPZI $PNPN $CNRC $SAGMF $CFTN $ADHC $TWOH $CBRA $EHVVF 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945565434134073473) 2025-07-16 19:25:21 UTC 4965 followers, XX engagements "🦉Body volume loss was sexually dimorphic: XX% of lost volume in men came from the trunk vs. XX% in women; women lost more from legs. BRI visualizations confirmed high baseline risk and partial normalization. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GIP #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946217858352230647) 2025-07-18 14:37:51 UTC 4964 followers, XXX engagements "🦉 GLP-1 agonists showed sustained protective effect on AUD over X years in long-term users. Duration-based data is rare in addiction pharmacotherapy studies highlighting this as a key finding. #GLP1 #Tirzepatide $NVO $LLY $VKTX $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041989490299263) 2025-07-20 21:12:39 UTC 4954 followers, XXX engagements "Regeneron and Sanofis Phase X Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946241580144222705) 2025-07-18 16:12:06 UTC 4966 followers, XXX engagements "🦉 In people with obesity or type X diabetes gut cells produce less GLP-1 weakening both glucose control and immune defenses in the gut. Chronic inflammation and high-fat diets worsen this decline especially as people age. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GLP1R"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945903574371664053) 2025-07-17 17:48:59 UTC 4965 followers, XXX engagements "🦉 Demographics: Mean BMI was XXXX (non-DM) vs XXXX (DM); age XXXX vs XXXX years; XXXX% vs XXXX% female. These differences likely influenced treatment responsiveness. #obesity #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946983221788311840) 2025-07-20 17:19:07 UTC 4964 followers, XXX engagements "🦉 REWIND showed dulaglutide reduced MACE in lower-risk T2DM patients; benefits driven by nonfatal stroke. But XX% discontinued by study end. Tolerability remains a limiting factor in long-term outcomes. #GLP1 #stroke $NVO $LLY $ZLDPF $VANI $HIMS $AZN"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947045781233344553) 2025-07-20 21:27:43 UTC 4954 followers, XXX engagements "🦉 Weekly titration to XXX mg liraglutide: XXXXX% reached target by week 3; XXXX% by week X. Suggests most patients tolerate standard escalation despite known GI side effects. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947022479731384490) 2025-07-20 19:55:07 UTC 4954 followers, XXX engagements "Hengrui Pharmas Potential Rival to El Lillys Zepbound Leads to XX% Weight Loss in Key Study $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945889200999444690) 2025-07-17 16:51:53 UTC 4960 followers, XXX engagements "🦉3D avatars built from Surmount-1 trial data show how tirzepatide reshaped male and female bodies after XX weeks. Men saw a BMI drop from XXXX to 30.8; women from XXXX to XXXX. Waistlines shrank by 1721 cm. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GIP #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946217854631563275) 2025-07-18 14:37:50 UTC 4966 followers, XXX engagements "🦉 Side effects in 27.8%: nausea (19.4%) diarrhea (27.8%) vomiting (8.3%) urticaria (5.5%). One exclusion: severe intolerance with Mallory-Weiss tear. GI side effects consistent with prior trials. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947021946748629324) 2025-07-20 19:53:00 UTC 4963 followers, XX engagements "🦉 GLP-1 RA metabolites like GLP-1 (936) act independently of the receptor enhancing endothelial recovery post-ischemia via cGMP/NO release. This expands their cardioprotective reach beyond classical GLP-1 signaling. #GLP1 #cardiovascular"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946296701368586318) 2025-07-18 19:51:08 UTC 4967 followers, XX engagements "💼GLP-1 and Its Analogs: Does Sex Matter $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #sex"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945881957348319743) 2025-07-17 16:23:06 UTC 4968 followers, XXX engagements "🦉 XXXX% vs 11.57%: Weight loss difference between diabetic and non-diabetic groups receiving semaglutide XXX mg. A clinically and statistically significant gap (p 0.001). #weightloss #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946982791356285270) 2025-07-20 17:17:25 UTC 4964 followers, XXX engagements "💼Out of Shortage Into Controversy: The Fight Over GLP-1 Compounding $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946582270531260916) 2025-07-19 14:45:53 UTC 4964 followers, XXX engagements "GLP-1 drug akin to Ozempic showed no benefits for Parkinsons disease $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945889323544420552) 2025-07-17 16:52:22 UTC 4965 followers, XXX engagements "Wegovy and Mounjaro: HSCC launches weight loss jab inquiry $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945887396500836424) 2025-07-17 16:44:42 UTC 4956 followers, XXX engagements "$capc $ltnc $wint $nwbo $dpls $btog $apm $etst $atvk $rakr $qind"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945894620006588725) 2025-07-17 17:13:25 UTC 4966 followers, 1679 engagements "🦉 In SUSTAIN-10 semaglutide reduced HbA1c and weight more than liraglutide but had higher GI side effects. Tirzepatidedual GLP-1/GIP agonistshowed superior glycemic control in meta-analysis. #Semaglutide #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947016561270608092) 2025-07-20 19:31:36 UTC 4954 followers, XX engagements "Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239540097700162) 2025-07-18 16:04:00 UTC 4967 followers, XXX engagements "🦉 The subcutaneous GLP-1/GIP agonist is now being evaluated beyond type X diabetes. A successful readout could widen its label and shift competitive dynamics in the diabetes treatment landscape. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946330840033530086) 2025-07-18 22:06:47 UTC 4968 followers, XXX engagements "Bristol Myers Squibbs Reblozyl fails Phase X in anemia; Sanofi Blueprint deal closes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239341543453065) 2025-07-18 16:03:13 UTC 4966 followers, XXX engagements "Novo-Nordisk A/S Foundation establishes a quantum company Magne Computer will be based in Denmark. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945886312768197037) 2025-07-17 16:40:24 UTC 4963 followers, XXX engagements "$NBND 🌐 $NWBO $AVXL $LWLG $EMED $AMRN $MVNT $COOP $HALO $SFWJ $BMXI $RDAR $VPLM $NLST $TGLO $RNVA $DRNK $FUNR"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945537075731697784) 2025-07-16 17:32:39 UTC 4966 followers, XX engagements "$cycc $BLNE $CTOR $PCSA $Btog $onmd $cyn $pew $sbet $ndra $wff $XXII $gctk $bglc $atnf $ptnm $VLCN 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945945105031889160) 2025-07-17 20:34:01 UTC 4962 followers, XXX engagements "🦉 In Crees PCOS trial X of XX semaglutide-treated women didnt lose XX% body weight. One lost none. Response variability mirrors obesity trial dataGLP-1s dont work equally for all phenotypes. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946964317863129280) 2025-07-20 16:04:00 UTC 4964 followers, XX engagements "Biocon targets launch for generic Wegovy in India by 2027 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945887001451925663) 2025-07-17 16:43:08 UTC 4956 followers, XXX engagements "Hims & Hers (HIMS) Faces Legal Storm Post Novo Nordisk Breakup $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890267266969858) 2025-07-17 16:56:07 UTC 4964 followers, XXX engagements "🦉 Facebook post claimed: Buying weight loss drugs just got easier. No prescription No problem. Violates Germanys HWG XX which restricts direct-to-consumer drug ads to certified medical personnel. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946970027241976217) 2025-07-20 16:26:42 UTC 4954 followers, XX engagements "Sanofi secures FDA fast-track status for SAR446597 in GA $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888441121509825) 2025-07-17 16:48:51 UTC 4964 followers, XXX engagements "Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July XX 2025 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945887922256785408) 2025-07-17 16:46:48 UTC 4964 followers, XXX engagements "🦉 In Dr. Melanie Crees trial on semaglutide for PCOS X of XX women (not on Metformin) lost over XX% of body weight after XX months. X reached normal testosterone levels; X reported more regular periods. #PCOS #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946962949945622626) 2025-07-20 15:58:34 UTC 4954 followers, XX engagements "🦉 Legal battles intensify as Eli Lilly sues the FDA challenging peptide vs. biologic classifications while brand manufacturers flood compounders with cease-and-desist letters. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946582276923412792) 2025-07-19 14:45:55 UTC 4963 followers, XXX engagements "$HCTI $GIBO $WLGS $NCNA $CGBS $GTI $GVH $TNFA $CHSN $OST $FOXO $DFLI $SISI $JYD $EVTV $ABP $ATCH $WCT $PTLE $HTCO $IXHL $NITO $DHAI $AIRE $ASBP $INTS $LPTX $XHLD $CYCU 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944810824469545050) 2025-07-14 17:26:48 UTC 4965 followers, XXX engagements "$BDPT 🌐 $NWBO $LWLG $GTCH $FNMA $NB $ELTP $RDGL $HMBL $COOP"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945535560874942497) 2025-07-16 17:26:38 UTC 4967 followers, XXX engagements "🦉 Eight GLP-1RAs approved for T2DM; two for obesity. Short-acting agents mainly slow gastric emptying; long-acting forms regulate both basal and postprandial glucose. Half-life affects efficacy. #GLP1 #diabetes $NVO $LLY $AZN $VKTX $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947017035193401826) 2025-07-20 19:33:29 UTC 4954 followers, XXX engagements "🦉 A one-time liver-targeted gene edit made mice produce Exendin-4 on their own. Treated mice ate less gained XX% less weight and had insulin levels and HbA1c close to healthy controls for XX weekswithout injections. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #diabetes"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944474960141156802) 2025-07-13 19:12:11 UTC 4962 followers, XXX engagements "🦉 In Wang et al.s retrospective cohort semaglutide use in obese patients was linked to a XX% lower risk of new AUD diagnosis and a XX% lower risk of recurrent AUD vs. naltrexone or topiramateboth approved AUD drugs. #GLP1 #Semaglutide $NVO $LLY $AZN"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947040941396660261) 2025-07-20 21:08:29 UTC 4954 followers, XXX engagements "Ohio lawmakers push to restore state employee access to weight loss drugs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240203976331328) 2025-07-18 16:06:38 UTC 4966 followers, XXX engagements "💼Microdosing: how off-label use of weight loss jabs is spreading from US to UK $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #UK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944479976381899217) 2025-07-13 19:32:07 UTC 4962 followers, XXX engagements "$CAPR 🌐 $SGN $FTFT $INKT $ZBAI $LMFA $BTOG $ARBK $WLGS $TAOX $CAPR $SPY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943663241034342769) 2025-07-11 13:26:42 UTC 4965 followers, XXX engagements "💼GLP-1 Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946677045829812294) 2025-07-19 21:02:29 UTC 4954 followers, XXX engagements "🦉 Tirzepatide adds GIP receptor activation lowering IL-5 and IL-13 in asthma and cutting apnea events by over 25/hour in obesity-related sleep apnea. Effects appear partly independent of weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945932790437941407) 2025-07-17 19:45:05 UTC 4965 followers, XXX engagements "Sanofi completes billion-dollar acquisition of Blueprint Medicines $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239493855498279) 2025-07-18 16:03:49 UTC 4966 followers, XXX engagements "🦉 Hamilton began semaglutide in Oct 2024 as part of a PCOS trial. Within X weeks: menstruation resumed. After XX months: lost XX lbs regrew hair reduced depression/anxiety. Diet/exercise were maintained throughout. #Semaglutide #PCOS $NVO $LLY $AZN"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946963452372648160) 2025-07-20 16:00:34 UTC 4963 followers, XX engagements "🦉 Most frequent side effects: nausea vomiting diarrhea constipation abdominal pain. Rare risks: pancreatitis and gallstones. Contraindicated in MEN X and medullary thyroid carcinoma. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946956689434935416) 2025-07-20 15:33:42 UTC 4955 followers, XXX engagements "🦉 YouTube had the highest average information score at 1.38/5; Instagram scored just XXXX. Despite high engagement visual-first platforms rarely mention drug mechanism ADRs or regulatory status. #Semaglutide #weightloss $NVO $LLY $AZN $SNY $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946968643738243216) 2025-07-20 16:21:12 UTC 4964 followers, XX engagements "Hengrui Pharmas Potential Rival to El Lillys Zepbound Leads to XX% Weight Loss in Key Study #glp-1marketing #feedly $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945204588199448973) 2025-07-15 19:31:28 UTC 4963 followers, XXX engagements "💼Lillys oral GLP-1 orforglipron showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines $LLY #GLP1 $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944823377442521484) 2025-07-14 18:16:40 UTC 4963 followers, XXX engagements "🦉 In XXX women with T2D oral semaglutide reduced HbA1c by XXX% at X months and XXX% at XX months. Median weight loss reached XXX% at XX months; XXXX% achieved XX% weight reduction. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946993750321901846) 2025-07-20 18:00:58 UTC 4962 followers, XXX engagements "🦉 Treatment mix: semaglutide weekly n=80; oral semaglutide n=20; liraglutide n=10; dulaglutide n=5. All treatment arms included in analysis. #Semaglutide #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947013291806478562) 2025-07-20 19:18:37 UTC 4954 followers, XXX engagements "💼GIPR-Ab/GLP-1 peptideantibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946666303185387520) 2025-07-19 20:19:48 UTC 4963 followers, XXX engagements "🦉 Effect sizes (Cohens d): waist circumference 1.01; triglycerides 0.53; HbA1c 0.51; final waist d=0.85; final BMI d=0.35; final HbA1c d=0.43. #obesity #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947013748012531730) 2025-07-20 19:20:25 UTC 4954 followers, XXX engagements "🦉 No increased atrial fibrillation risk from GLP-1 RAs in a meta-analysis of XX RCTs. Separate semaglutide-specific data suggest possible AF reductionmechanism likely indirect via weight and inflammation. #GLP1 #AFib $NVO $LLY $AZN $SNY $VKTX $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947046977314648429) 2025-07-20 21:32:28 UTC 4954 followers, XXX engagements "🦉 Three retrospective studies support GLP-1 efficacy in reducing: (1) AUD onset (2) AUD recurrence (3) intoxication events (4) hospitalizationsacross US and Nordic cohorts. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041619758268466) 2025-07-20 21:11:11 UTC 4954 followers, XXX engagements "🦉 The weight loss effect of the GIPR-Ab/GLP-1 conjugate hinges on functional GIPR and GLP-1R in the brain not just in the periphery. Blocking GIPR in neurons amplified GLP-1R agonist efficacy. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946666306616324213) 2025-07-19 20:19:49 UTC 4954 followers, XXX engagements "🦉 Female sex high baseline BMI and absence of diabetes are emerging predictors of superior response to semaglutide. Supports patient stratification in obesity care. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946983810643493355) 2025-07-20 17:21:28 UTC 4964 followers, XXX engagements "GLP1 receptor agonist drug treatments and adult obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888681996238947) 2025-07-17 16:49:49 UTC 4960 followers, XXX engagements "🦉 CNS knockout of either receptor cut efficacy nearly in half even with intact peripheral signaling. The compound reached the brain via circumventricular organs and activated appetite-suppressing circuits. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946666309753696371) 2025-07-19 20:19:50 UTC 4964 followers, XXX engagements "🦉 Facebook post claimed: Buying weight loss drugs just got easier. No prescription No problem. Violates Germanys HWG XX which restricts direct-to-consumer drug ads to certified medical personnel. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946969370111934919) 2025-07-20 16:24:05 UTC 4964 followers, XX engagements "🦉 XXX X% final HbA1c in DD vs. XXX XXX% in nonDD (p=0.01). Yet HbA1c: XXX XXX% vs. XXX XXX% (p=0.8) baseline difference not treatment attenuation. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947013229835665775) 2025-07-20 19:18:22 UTC 4954 followers, XXX engagements "Sanofis New RSV Vaccine Study: What Investors Need to Know $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946241638734377168) 2025-07-18 16:12:20 UTC 4966 followers, XXX engagements "💼GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GLP1R"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945903570982682820) 2025-07-17 17:48:59 UTC 4962 followers, XXX engagements "Emcure Pharmaceuticals Partners with Sanofi India to Distribute Amaryl and Cetapin for Diabetes Management $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240604679082189) 2025-07-18 16:08:14 UTC 4966 followers, XXX engagements "$BDPT $LWLG $NWBO $GTCH $FNMA $NB $ELTP $RDGL $HMBL $COOP 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945563481920389180) 2025-07-16 19:17:35 UTC 4967 followers, 1380 engagements "$NVCR $SNDX $DCTH $AUTL $GERN $DAWN $IMCR $XBI 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946647320457519417) 2025-07-19 19:04:22 UTC 4955 followers, XXX engagements "🦉 Energy metabolism shift: GLP-1 agonists promote lipid over carb utilization. Preserves muscle glycogen. Exendin-4 induces mitochondrial biogenesis in muscle. AMPK stability vital. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947017223052104019) 2025-07-20 19:34:14 UTC 4954 followers, XXX engagements "🦉 In the SELECT trial weekly semaglutide reduced non-fatal MI in patients with ASCVD but no diabetes. In contrast trials like EXSCEL and ELIXA showed no MI reduction in broader T2DM populations. #GLP1 #diabetes $NVO $LLY $AZN $SNY $VKTX $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947045490840797599) 2025-07-20 21:26:34 UTC 4954 followers, XXX engagements "Doctor issues severe warning to Ozempic users as hundreds make worrying diet admission $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240702171455664) 2025-07-18 16:08:37 UTC 4966 followers, XXX engagements "💼GLP-1 Receptor Agonists: Encouraging Signals for Treating Alcohol Use Disorder $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946675314291044758) 2025-07-19 20:55:37 UTC 4965 followers, XXX engagements "💼Optic Neuropathy and Other Hidden Ocular Risks of GLP-1 RA Weight Loss Drugs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944821845150085539) 2025-07-14 18:10:35 UTC 4963 followers, XXX engagements "💼 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945912432225878024) 2025-07-17 18:24:11 UTC 4965 followers, XXX engagements "🦉 GLP-1Rs in synovium and cartilage regulate TNF- IL-6 IL-1. Liraglutide and dulaglutide reduced MMP-3/13 ADAMTS4/5 and ROS. Results: decreased chondrocyte apoptosis and joint degradation. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947033677231251726) 2025-07-20 20:39:37 UTC 4954 followers, XXX engagements "💼Ita Asset Management and KKR form Exclusive Strategic Partnership in Brazil to Broaden Private Market Investment Opportunities in Latin Americas Largest Market #investment #Brazil $KKR $ITUB"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1942929804610662860) 2025-07-09 12:52:17 UTC 4962 followers, XXX engagements "$NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $GOOGL $AMZN $NVDA $SOFI $TSLA $AMD $PINS $AAPL $NU $COIN $RDDT $TTD $NVTS $OSCR $LULU $NKETop $VKTX $DAWN $TMDX $AXSM $TRVI $TGTX $MREO $CRVS $MDGL $LLY $OCUL $HIMS $PDSB $LRMR 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1942591684321194236) 2025-07-08 14:28:43 UTC 4965 followers, XXX engagements "Denmarks EIFO and Novo Nordisk Foundation acquire worlds most powerful quantum computer from Microsoft $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240775173312967) 2025-07-18 16:08:54 UTC 4965 followers, XXX engagements "$BBIO $SLDB $GPCR $UNH $IOVA $SRPT $CYTK $DRUG $MDNAF $NKTR 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1942591781981544542) 2025-07-08 14:29:07 UTC 4962 followers, 2277 engagements "💼Why are we still in need for novel anti-obesity medications $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945879587306516798) 2025-07-17 16:13:40 UTC 4967 followers, XXX engagements "🦉 GLP-1 increases hepatic glycogen even in absence of insulin via PI3K-AKT signaling. DCA and GRb also trigger this independently highlighting a non-insulin glycogenic route. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947017596412330266) 2025-07-20 19:35:43 UTC 4954 followers, XXX engagements "💼Health Rounds: GLP-1 obesity drugs may boost low testosterone $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946978917585146130) 2025-07-20 17:02:01 UTC 4954 followers, XXX engagements "🦉 Combined metabolic response5% weight loss plus X% HbA1c reductionwas reached by XXXX% at X months and XXXX% at XX months. Most effective in women with baseline HbA1c X% and BMI XX. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946994084066840754) 2025-07-20 18:02:17 UTC 4962 followers, XX engagements "🦉 In X RCTs (n=1872) with type X diabetes patients once-weekly semaglutide XXX mg led to a mean weight reduction of XXXX% (95% CI: XXXX to 5.69) vs placebo. No heterogeneity (I = 0%). #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946982602767737201) 2025-07-20 17:16:40 UTC 4964 followers, XX engagements "$KURA $RPTX $TCRX $IOVA $ACRV $NUVB $RCKT $IDYA $DCTH $RYTM $TARS $ARQT $ASND 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1940906922888384697) 2025-07-03 22:54:05 UTC 4965 followers, XXX engagements "🦉 Hypertension prevalence: DD XXXX% vs. nonDD XX% (p=0.001). Dyslipidemia: XXXX% vs. XXXX% (p=0.04). No differencesretinopathy macrovascular disease hypoglycemic admissions. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947013833567908115) 2025-07-20 19:20:46 UTC 4954 followers, XXX engagements "Glucagon-like Peptide-1 Receptor Agonist Therapy Is Associated With Fewer Medical Complications After Carpal Tunnel Release in Diabetic Patients $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890529880707319) 2025-07-17 16:57:09 UTC 4963 followers, XXX engagements "Health Rounds: GLP-1 obesity drugs may boost low testosterone $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890703755657402) 2025-07-17 16:57:51 UTC 4965 followers, XXX engagements "💼The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart Disease $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #cardiology #diabetes"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944477255872487722) 2025-07-13 19:21:19 UTC 4962 followers, XXX engagements "💼Impact of Sleeping Habits on the Weight Loss Effect of Oral Glucagon-Like Peptide-1 Receptor Agonists Among Obese Patients: An Observational Study in Japan $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #sleep #obesity #Japan"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944436446120534366) 2025-07-13 16:39:09 UTC 4965 followers, XXX engagements "MediPharm Labs Closes $XXX Million Sale of Hope BC $LABS $MEDIF $ROMJ $ROMJF $YOLO"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1930611716183797968) 2025-06-05 13:04:36 UTC 4960 followers, XX engagements "$NKTR $CRVS Conjunctivitis has emerged as a persistent adverse effect tied specifically to IL-4/IL-13 pathway inhibition in atopic dermatitis (AtD) biologics like Dupixent and Ebglyss. New evidence links this to IL-4RA expression on conjunctival goblet cellscreating an inherent ocular vulnerability in this mechanism. This opens a differentiated safety windowand possibly a major market advantagefor $NKTR (Rezpeg) and $CRVS (Soquelitinib). Both use novel mechanisms (Treg proliferation and ITK inhibition respectively) and have shown zero conjunctivitis events across XXX patients combined. If"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1942579751937294778) 2025-07-08 13:41:18 UTC 4965 followers, 1795 engagements "Hims & Hers Brass Face Suit Over 'Knockoff' Wegovy Sales $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945889402749591804) 2025-07-17 16:52:41 UTC 4965 followers, XXX engagements "🦉 Semaglutide showed the lowest dropout rate due to side effects and fewer severe GI issues than liraglutide despite nausea remaining frequent in early use. Tolerability remains its comparative edge. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946587002935103913) 2025-07-19 15:04:41 UTC 4963 followers, XXX engagements "$LYFT $PROK $ZVSA $BTCS $NDRA $LSB $SRFM $BSLK $RLYB $ITP $SQNS $SPY 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1942664895859949777) 2025-07-08 19:19:38 UTC 4952 followers, XXX engagements "🦉 Brown adipose tissue (BAT) immune-regulated. Neuronal GLP-1R deletion energy expenditure UCP1. iNKT cells and monocyte IL-6 activation mediate BAT thermogenesis via GLP-1. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947016838233174308) 2025-07-20 19:32:42 UTC 4954 followers, XXX engagements "🦉 Dropout rate in women: 18.2%. Main reasonsGI intolerance (9.8%) and lack of follow-up (4.4%). No severe adverse events reported; discontinuation not linked to any baseline factor. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946994720879579144) 2025-07-20 18:04:49 UTC 4962 followers, XXX engagements "Lillys Zepbound faces a potential weight-loss rivalmade by a Chinese biotech $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945889036834324678) 2025-07-17 16:51:13 UTC 4960 followers, XXX engagements "🦉 Among those with metabolic liver disease and diabetes GLP-1 agonists reduced cirrhosis its complications and mortality versus DPP-4 inhibitors. Alcohol-related liver risk may be mitigated. #GLP1 #diabetes $NVO $LLY $AZN $SNY $VKTX $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041529182199943) 2025-07-20 21:10:49 UTC 4954 followers, XXX engagements "💼Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945911413567877518) 2025-07-17 18:20:08 UTC 4963 followers, XXX engagements "🦉 Sipes prescribed Zepbound in Sep 2024 lost 60+ lbs in X months. Symptoms improved: regular periods reduced cysts joint pain cravings. GLP-1s may modify inflammatory and hormonal drivers of PCOS. #Zepbound #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHB"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946963593833882047) 2025-07-20 16:01:08 UTC 4962 followers, XX engagements "💼GLP-1 and the Neurobiology of Eating Control: Recent Advances $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945909783665442924) 2025-07-17 18:13:40 UTC 4962 followers, XXX engagements "$JUSHF $MSOS $YOLO $PSIL $CXXIF $GLASF 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1943661722511847432) 2025-07-11 13:20:40 UTC 4964 followers, XXX engagements "FDA staff express uncertainty regarding usefulness dosing of Sanofi's diabetes therapy iGlarLixi $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944170751311196560) 2025-07-12 23:03:22 UTC 4962 followers, XXX engagements "Viking Therapeutics: What's Next After GLP-1 Hype Dies Down And Competition Intensifies $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944171597155512394) 2025-07-12 23:06:44 UTC 4962 followers, XXX engagements "FDA grants fast track designation to Sanofis SAR446597 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945886573410582993) 2025-07-17 16:41:26 UTC 4964 followers, XXX engagements "Novo Nordisk Foundation and EIFO buy world's most powerful quantum computer $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945887163125580255) 2025-07-17 16:43:47 UTC 4960 followers, XXX engagements "🦉 Dr. Cree's trial spans ages 1235 with PCOS and obesity. It compares semaglutide effects on those with and without Metformin measuring weight hormones ovulation and age-related response over XX months. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946963930879766907) 2025-07-20 16:02:28 UTC 4962 followers, XX engagements "Hims & Hers plans Canada expansion to time patent cliff for Novos Weogvy $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944170607291379786) 2025-07-12 23:02:48 UTC 4962 followers, XXX engagements "Novo Nordisk to buy worlds most powerful quantum computer from Microsoft $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945886486794060062) 2025-07-17 16:41:05 UTC 4965 followers, XXX engagements "B.C. limits sale of X more diabetes drugs used for weight loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240258481262857) 2025-07-18 16:06:51 UTC 4961 followers, XXX engagements "Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888037356851613) 2025-07-17 16:47:15 UTC 4963 followers, XXX engagements "🦉 New dual agonists like tirzepatide intensify appetite suppression but side effects like muscle loss and facial fat wasting complicate long-term use without new mitigation strategies. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945911417422356965) 2025-07-17 18:20:09 UTC 4965 followers, XXX engagements "Union health plan sues Optum Rx for covering costly weight loss drugs including Wegovy $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946241411642204429) 2025-07-18 16:11:26 UTC 4966 followers, XXX engagements "Thermo Fisher buys Sanofi factory; Amphastar Pharma quadruples HQ capacity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945885947670700504) 2025-07-17 16:38:57 UTC 4960 followers, XXX engagements "💼Shifting obesity treatment paradigms: Trends of glucagon-like peptide-1 receptor agonists and bariatric surgery in the United States $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946221965389316419) 2025-07-18 14:54:10 UTC 4954 followers, XXX engagements "🦉 1200000 likes on TikTok vs. 137807 on YouTube: Most-liked posts lacked drug mechanism indications or cost data. Popularity accuracy. Visual appeal outweighs pharmacological content. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946968870100652499) 2025-07-20 16:22:06 UTC 4964 followers, XX engagements "🦉 Retrospective studies: Semaglutide lowered 2-year rotator cuff retear rate and reduced infection risk post-arthroscopic repair in T2DM. Also reduced readmissions after spinal fusion. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947034480218169384) 2025-07-20 20:42:48 UTC 4954 followers, XXX engagements "💼Advances in GLP-1 receptor agonists for pain treatment and their future potential $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946688313043075431) 2025-07-19 21:47:16 UTC 4954 followers, XXX engagements "🦉 Amgens maridebart cafraglutide cut weight by up to XX% in patients without diabetes and XX% in those with T2D outperforming placebo by X to 13x. No plateau by week XX suggests ongoing efficacy. $AMGN $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GIP #Obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945613389704958300) 2025-07-16 22:35:54 UTC 4955 followers, XXX engagements "Doctor issues urgent advice as hundreds of weight-loss jab users share concerns over diet $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890068364738724) 2025-07-17 16:55:19 UTC 4960 followers, XXX engagements "🦉 Swedish-Danish registry study: GLP-1 agonists not linked to increased risk of suicide self-harm depression or anxiety. Suggests neuropsychiatric safety in AUD-relevant populations. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041382784262395) 2025-07-20 21:10:14 UTC 4954 followers, XXX engagements "🦉 ADA 2025: GLP-1 RAs (SGLT2i) recommended to prevent MACE in T2DM with ASCVDirrespective of HbA1c or metformin. Highest A-grade evidence. ESC ACC/AHA guidelines also aligned for chronic coronary disease. #GLP1 #ASCVD $NVO $LLY $AZN $SNY $VKTX $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947047082365186182) 2025-07-20 21:32:53 UTC 4954 followers, XXX engagements "🦉 The DNA-based biosensor tracked phenylalanine shifts tied to protein intake and muscle degradation. Tested up to 1500 M/L it stayed stable over X days offering potential for clinical use in GLP-1 and aging care. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944470807574417508) 2025-07-13 18:55:41 UTC 4965 followers, XXX engagements "🦉 Benefits scale with treatment intensity: higher GLP-1 doses and longer use produce stronger outcomes. Semaglutide ranked best for both weight loss and cardioprotection among GLP-1 drugs. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944482871932047669) 2025-07-13 19:43:38 UTC 4962 followers, XXX engagements "$SMCE $HMBL $DTREF $GTCH $SAPX $IGPK $ENTA $AFFU $TWOH $RITE $ADHC $FITY $CYBL $GTCH $NWBO $FNMA $ELTP $AVXL $PSRU $COOP $AFFU $CGAC $PSWW 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946259046526304417) 2025-07-18 17:21:31 UTC 4965 followers, XX engagements "Targeted in vivo gene integration of a secretion-enabled GLP-1 receptor agonist reverses diet-induced non-genetic obesity and pre-diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944172230419595597) 2025-07-12 23:09:15 UTC 4965 followers, XXX engagements "🦉 Among 3842 non-diabetic participants in X RCTs the same semaglutide dose achieved a mean weight loss of XXXXX% (95% CI: XXXXX to 10.19). Heterogeneity was moderate (I = 63.3%). #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946982680748314742) 2025-07-20 17:16:58 UTC 4965 followers, XXX engagements "💼What are drugs like Ozempic doing to the brains of people that binge eat $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946977751434465499) 2025-07-20 16:57:23 UTC 4954 followers, XXX engagements "$NWBO $RDAR $HPNN $TPTW $HMBL $CBDD $GRLT $HCMC $AITX $DPLS $FNMA ✍"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945535970176029138) 2025-07-16 17:28:16 UTC 4964 followers, XXX engagements "💼Ozempic and Wegovy may cut dementia risk by XX% and manage d. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #ozempic #wegovy"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946965093159211059) 2025-07-20 16:07:05 UTC 4954 followers, XXX engagements "🦉 With FDA removing semaglutide and tirzepatide from its shortage list 503A pharmacies now face stricter compounding rules tied to essentially a copy standards and specific clinical difference justifications. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946582273471504558) 2025-07-19 14:45:54 UTC 4963 followers, XXX engagements "Press Release: Sanofi announces extension of Blueprint tender offer - 17.07.25 - News $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888966047138212) 2025-07-17 16:50:57 UTC 4965 followers, XXX engagements "🦉 Waist circumference: DD group XXXXX XXXX cm vs. XXXXX XXX cm (p=0.001). At followup persisted: XXX XXX cm vs. XXX XXX cm (p=0.001). #obesity #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947012722568134775) 2025-07-20 19:16:21 UTC 4964 followers, XX engagements "🦉 X mmHg SBP reduction with tirzepatide in SURMOUNT-1 paired with XX% weight loss at XX mg dose. Far surpasses BP and weight changes in GLP-1 RA trials likely from dual GIPR/GLP-1 mechanism. #Tirzepatide #obesity $NVO $LLY $AZN $SNY $VKTX $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947046570475569177) 2025-07-20 21:30:51 UTC 4954 followers, XXX engagements "$NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945912009024790835) 2025-07-17 18:22:30 UTC 4965 followers, XXX engagements "In this cross-sectional study we collected posts and comments from the X most active GLP-1 medicationrelated forums on a social media website (Reddit; Advance Publications) in July 2024. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946585927976882206) 2025-07-19 15:00:25 UTC 4965 followers, XXX engagements "🦉 XXXX% of Instagram before/after posts were likely AI-generated (DeepFake-o-meter). TikToks average was 51.6%. High AI use may distort expectations and fuel unregulated semaglutide use. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946969136958972036) 2025-07-20 16:23:09 UTC 4965 followers, XX engagements "🦉 Persistence rate in women using oral semaglutide was XXXX% over one year. Despite GI intolerance in nearly X in XX overall adherence was high and similar to previous GLP-1 RA studies. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946995411446648973) 2025-07-20 18:07:34 UTC 4962 followers, XXX engagements "🦉 Dopaminergic modulation. GLP-1 agonists suppress mesolimbic dopamine. May reduce reward-seeking behavior but raise risk of depression in DRD2 Taq1A polymorphism carriers. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947017395169538453) 2025-07-20 19:34:55 UTC 4954 followers, XXX engagements "🦉 The therapy used lipid nanoparticles to deliver CRISPR components achieving X% knock-in at the albumin gene with no off-target edits. A second dose doubled Exendin-4 output. Safety markers like liver enzymes stayed normal. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #diabetes"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944474963328790595) 2025-07-13 19:12:12 UTC 4956 followers, XXX engagements "🦉 In just six weeks tirzepatide slashed calorie intake by 72%without participants trying to restrict food. Unlike semaglutide or liraglutide it blunted hunger by rewiring activity in key brain regions tied to cravings. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946333627115073897) 2025-07-18 22:17:52 UTC 4968 followers, XXX engagements "🦉 GLP-1 drugs drive weight loss mainly by suppressing appetite not by boosting energy use. But once stopped most users regain up to XX% of the lost weightdespite diet and exercise. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945911415623049597) 2025-07-17 18:20:09 UTC 4965 followers, XXX engagements "Viking Therapeutics (VKTX) Soars XXX% on Looming Weight Loss Drug Trial Results $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944171416108380177) 2025-07-12 23:06:01 UTC 4962 followers, XXX engagements "🦉 STEP X (DM): XXX% weight loss. STEP X and X (non-DM): 15%. Meta-analysis confirms the trenddiabetes dampens semaglutide efficacy in weight loss. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946983494241939882) 2025-07-20 17:20:12 UTC 4964 followers, XX engagements "🦉 Odds ratios in DD group: hypertension OR=7.44 (95% CI 1.6134.46); nephropathy OR=5.14 (1.6216.35); female sex OR=2.77 (1.266.06). #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947013561089192237) 2025-07-20 19:19:41 UTC 4954 followers, XXX engagements "🦉 G2 improved HDL-C significantly: +0.27 mmol/L (p = 0.001) vs. G1s +0.004 mmol/L (p = 0.049). LDL-C reduction also greater in G2 (0.17 mmol/L; p = 0.004). Suggests stronger lipid modulation. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947021738513977595) 2025-07-20 19:52:11 UTC 4963 followers, XX engagements "🦉 Blood pressure lowered within X weeks of liraglutide therapy suggesting vascular effects beyond weight loss. DURATION-1 showed XXX mmHg SBP drop with exenatide X mg/week; other trials reported less. #GLP1 #bloodpressure $NVO $LLY $AZN $SNY $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947046354645094865) 2025-07-20 21:29:59 UTC 4954 followers, XXX engagements "💼Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946674710277759282) 2025-07-19 20:53:13 UTC 4962 followers, XXX engagements "🦉 Eli Lilly has launched a double-blind Phase X trial of tirzepatide in overweight adults with type X diabetes a group with few targeted therapies. The drug is being tested for glycemic control and weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946330838053851563) 2025-07-18 22:06:47 UTC 4968 followers, XXX engagements "💼Case-Based Review of Breast Imaging Changes Associated With GLP-1 Agonists $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946676638097223962) 2025-07-19 21:00:52 UTC 4965 followers, XXX engagements "Novel glucose-lowering agents that benefit diabetic foot: icing on the cake $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888206664220695) 2025-07-17 16:47:55 UTC 4954 followers, XXX engagements "🦉 Sulfonylurea and insulin use in DM may blunt weight reduction from GLP-1 agonists. Insulin promotes fat storage opposing the catabolic effects of semaglutide. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946983686815035637) 2025-07-20 17:20:58 UTC 4954 followers, XXX engagements "🦉 One hormone three effectsstimulates insulin (when glucose is high) suppresses glucagon and delays gastric emptying. Together these regulate post-meal glucose and appetite with high precision. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946955603160822135) 2025-07-20 15:29:23 UTC 4962 followers, XX engagements "🦉 A new trial found semaglutide helped people with type X diabetes lose fat and spend more time in healthy blood sugar rangesomething older GLP-1 drugs never really delivered on. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946284755256823881) 2025-07-18 19:03:40 UTC 4967 followers, XXX engagements "💼GLP-1 and GIP Combination Shows Promise for Weight Loss Cardiometabolic Improvement in Obesity $AMGN $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GIP #Obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945613387385188521) 2025-07-16 22:35:53 UTC 4967 followers, XXX engagements "🦉 GLP-1s may benefit PCOS by lowering insulin. Lower insulin reduces ovarian androgen outputcutting testosterone and improving symptoms like acne hirsutism and cycle irregularity. Mechanism is indirect but consistent. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946963166405054899) 2025-07-20 15:59:26 UTC 4963 followers, XX engagements "🦉 STEP-HFpEF: semaglutide improved weight 6MWD and QoL in obese HFpEF patients. HF events decreased. Although underpowered for outcomes results support larger trials. Weight loss may be the driver. #Semaglutide #HFpEF $NVO $LLY $AZN $SNY $VKTX $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947046854476091744) 2025-07-20 21:31:59 UTC 4954 followers, XXX engagements "💼Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors #GLP1 #cardiovascular"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946296695760781723) 2025-07-18 19:51:07 UTC 4967 followers, XX engagements "🦉 FIGHT and LIVE trials: liraglutide failed to improve outcomes in HFrEF. LIVE reported more ventricular tachycardia and ischemiapossibly tied to increased heart rate a known GLP-1 RA side effect. #GLP1 #heartfailure $NVO $LLY $AZN $SNY $VKTX $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947046093037916672) 2025-07-20 21:28:57 UTC 4954 followers, XXX engagements "Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945887841470259368) 2025-07-17 16:46:28 UTC 4960 followers, XXX engagements "🦉 XX% of semaglutide users on social media took it for weight loss or PCOS not diabetes. Ozempic FDA-approved for T2D only was used off-label in almost all TikTok and Instagram content. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946967862448402703) 2025-07-20 16:18:05 UTC 4964 followers, XX engagements "🦉 GLP-1 receptor agonists are emerging as multi-target tools in chronic respiratory disease reducing inflammation oxidative stress and bronchial remodeling through CNS and immune modulation. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945932787162161289) 2025-07-17 19:45:04 UTC 4964 followers, XXX engagements "🦉 In STEP trials semaglutide + lifestyle changes produced XX% average weight losspreviously only seen with bariatric surgery. Weekly injection and daily oral tablet formulations exist. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946955498491695408) 2025-07-20 15:28:58 UTC 4962 followers, XXX engagements "🦉 Correlations: female sex + weight loss (r=0.2 p=0.02); insulin use weight loss (r=0.347 p0.001); alcohol XX g/day weight loss (r=0.229 p=0.01). #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947013351105589605) 2025-07-20 19:18:51 UTC 4954 followers, XXX engagements "🦉 Benefits even extend to osteoporosis cardiovascular damage and PCOS. Some effects come through GLP-1R-independent pathways making these drugs surprisingly versatile across diseases. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945900491814117589) 2025-07-17 17:36:44 UTC 4960 followers, XXX engagements "$NCNA $HCTI $SPZI $PNPN $CNRC $SAGMF $CFTN $ADHC $TWOH $CBRA $EHVVF ✍"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945565498952855812) 2025-07-16 19:25:36 UTC 4962 followers, XXX engagements "🦉 Analysis of XX RCTs covering 48891 patients shows GLP-1 therapy cuts MACE risk by XX% lowers weight by XXX kg and reduces systolic BP by XXX mmHg. All without needing a diabetes diagnosis. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944482869528744440) 2025-07-13 19:43:37 UTC 4964 followers, XXX engagements "🦉 Investigational scope widening: GLP-1 RAs show promise in neurodegenerative diseases NAFLD PCOS and even addictionvia anti-inflammatory and neuroprotective mechanisms. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946956518991020408) 2025-07-20 15:33:01 UTC 4962 followers, XXX engagements "AbbVies Skyrizi Novos Wegovy duke it out in Q2 TV ad spending totals $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890486327132523) 2025-07-17 16:56:59 UTC 4964 followers, XXX engagements "🦉 XX% and XX% lower risk of AUD-related hospitalization with semaglutide and liraglutide respectively per Swedish population-wide analysis. Approved AUD meds reduced this risk by only 2%. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041177011617904) 2025-07-20 21:09:25 UTC 4954 followers, XXX engagements "🦉 X XXX% weight loss in DD vs. XXX XXX% in nonDD (p=0.4). BMI weight waist reduction showed no significant group difference. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947013042060800193) 2025-07-20 19:17:37 UTC 4954 followers, XXX engagements "🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists In SELECT (Kushner 2025) semaglutide XXX mg reduced serious adverse events in obese CVD patients. GI side effects caused higher discontinuation. #SELECT #safety $NVO $SNY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946938377426849879) 2025-07-20 14:20:56 UTC 4965 followers, XX engagements "🦉 306K Instagram posts under #ozempic; yet only X% of creators referenced type X diabetes. Off-label demand has overwhelmed supplydespite Ozempic's limited approval scope and contraindications. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946970127204864139) 2025-07-20 16:27:05 UTC 4962 followers, XXX engagements "🦉 Despite lack of VAT difference liraglutide reactivated GLUT4 MAPK PPAR- reduced TGF- and lowered TNF- IL-6 IL-1. Mechanisms may explain stronger metabolic benefit in T2D. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947022791795998986) 2025-07-20 19:56:22 UTC 4954 followers, XXX engagements "$capc $hmbl $gtch $atvk $qind $ipsi $rdar $psww $psru $rkar $hysr $shmp $nwbo $smce $hcti 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946260862584463633) 2025-07-18 17:28:44 UTC 4954 followers, 2197 engagements "Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890631953395798) 2025-07-17 16:57:34 UTC 4960 followers, XXX engagements "Ozempic Wegovy: X factors may influence weight loss results $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944168049797398700) 2025-07-12 22:52:38 UTC 4962 followers, XXX engagements "Researchers Explore Potential of Ozempic in Addressing Addiction Through Brain Reward Pathways $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888267305451850) 2025-07-17 16:48:10 UTC 4965 followers, XXX engagements "🦉 With the study launched in late June early metabolic data could shape investor expectations. If absorption and excretion align the asset may gain strategic weight in Eli Lillys early pipeline. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946006834348761373) 2025-07-18 00:39:19 UTC 4965 followers, XXX engagements "🦉 Karim began Mounjaro via Noom in April 2024. After years of symptoms including a 5-month-long period treatment led to weight loss and symptom relief. Later used compounded version amid access barriers. #Mounjaro #PCOS $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946963704349610207) 2025-07-20 16:01:34 UTC 4965 followers, XX engagements "🦉 12-week oral semaglutide study: XXXX% energy intake vs placebo stronger satiety appetite control. Effects due to increased PYY decreased postprandial GLP-1 and cravings. #Semaglutide #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947017690972872867) 2025-07-20 19:36:06 UTC 4954 followers, XXX engagements "🦉 GLP-1-based drugs calm overactive immune cells lowering inflammation in the gut fat liver and blood vessels. But their effects depend on sex time of day and gut bacteriafactors that may explain why side effects and results vary so much. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GLP1R"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945903578389836012) 2025-07-17 17:49:00 UTC 4965 followers, XXX engagements "Fake weight loss drugs spark alarm: Warning sent to FDA FTC over counterfeit GLP-1s $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240470494916976) 2025-07-18 16:07:42 UTC 4966 followers, XXX engagements "💼This Obesity Drug Cuts Calorie Intake by XX% Without Dieting $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946333624615227821) 2025-07-18 22:17:51 UTC 4954 followers, XXX engagements "💼New investigation launched after health experts find potentially fatal side effect of taking weight loss drugs According to UK reports there have been approximately XX deaths linked to this condition thanks to the GLP1 drugs. $NVO $LLY $AZN $SNY $GSK"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946971559874228571) 2025-07-20 16:32:47 UTC 4954 followers, XX engagements "🦉 XXX T2DM patients treated with GLP1 RAs X months: XXXX% (53/115) had documented depressive disorder (DD) via clinical diagnosis chronic antidepressants or BDI XX. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947012421920387289) 2025-07-20 19:15:09 UTC 4962 followers, XXX engagements "🦉 XXX mg/day liraglutide over X months: G2 (obesity + T2D) had greater A1c% reduction (1.15%; p = 0.001) vs. G1 (obesity + prediabetes) (0.5%; p = 0.000). Indicates enhanced glycemic response in T2D. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947021275328635185) 2025-07-20 19:50:20 UTC 4954 followers, XX engagements "💼Eli Lillys New Study on Tirzepatide: Potential Game-Changer for Type X Diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946330835826696446) 2025-07-18 22:06:46 UTC 4964 followers, XXX engagements "🦉 Less than X% of U.S. individuals with AUD use medications despite FDA approval. GLP-1RA usealready XX% of adults as of 2024may create off-label opportunities to fill this treatment gap. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947041728101314659) 2025-07-20 21:11:36 UTC 4954 followers, XXX engagements "🦉 In obese mice: GLP-1RA upregulated muscle oxidative fibers glycogen stores and mitochondrial activity. In humans muscle fatty infiltration decreased despite modest SMI reduction. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947033544569610728) 2025-07-20 20:39:05 UTC 4956 followers, XXX engagements "🦉 Despite record-breaking weight loss results current drugs face real-world barriers: high drop-out rates lean mass loss and fast weight regain after stopping. Their long-term utility remains fragile. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945879589638549688) 2025-07-17 16:13:41 UTC 4956 followers, XXX engagements "🦉 LEADER trial: liraglutide reduced major cardiovascular events in type X diabetes patients. Heart protectionnow a confirmed clinical endpoint for several GLP-1 receptor agonists. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946956227721765198) 2025-07-20 15:31:52 UTC 4954 followers, XXX engagements "🦉 Despite anecdotal benefit GLP-1s are not FDA-approved for PCOS. No endpoints exist for PCOS trials slowing drugmaker interest. Insurance often wont cover off-label use leaving patients with $1000/month costs. #PCOS #insurance $NVO $LLY $AZN $SNY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946964198019231923) 2025-07-20 16:03:32 UTC 4955 followers, XX engagements "🦉 How to enhance natural GLP-1 output: 1) Prioritize protein fiber and healthy fats. 2) Regular cardio + resistance training. 3) Fermented foods. 4) Sleep X hrs. 5) Stress control. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946956795815039355) 2025-07-20 15:34:07 UTC 4962 followers, XXX engagements "💼Beyond Blood Sugar: A Scoping Review of GLP-1Receptor Agonists in Cardiovascular Care $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946688737531846715) 2025-07-19 21:48:57 UTC 4954 followers, XXX engagements "🦉 Use of GLP-1 drugs like semaglutide skyrocketed XX times in just six years while weight-loss surgeries dropped 65%a trend that actually started before the drugs took off. Semaglutide is now the top choice. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946221968765685902) 2025-07-18 14:54:11 UTC 4966 followers, XXX engagements "🦉 All patients showed clinical insulin resistance signs. Baseline visceral fat: G1 = XXXX (IQR 830); G2 = XXXX (IQR 920). Liraglutide improved insulin sensitivity in both. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947022697302573511) 2025-07-20 19:55:59 UTC 4954 followers, XXX engagements "💼Study finds patients with interrupted GLP-1 access still achieve significant weight loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946286542940500158) 2025-07-18 19:10:46 UTC 4954 followers, XXX engagements "Could weight loss drugs like Ozempic help combat addiction $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888381042311566) 2025-07-17 16:48:37 UTC 4960 followers, XXX engagements "Novel oral agents in anti-obesity pharmacotherapy: A narrative review $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945204788167090644) 2025-07-15 19:32:16 UTC 4963 followers, XXX engagements "💼As a reporter I've covered all things GLP-1. Here's what I've learned. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946965722355093718) 2025-07-20 16:09:35 UTC 4954 followers, XXX engagements "🦉 Baseline metabolic disparity: DD group had HbA1c XXX X% vs. XXX XXX% (p=0.01); fasting glucose XXXXX XXXX vs. XXXXX XXXX mg/dL (p=0.02); triglycerides XXXXX XXXXX vs. XXXXX XXXX mg/dL (p=0.001). #GLP1 #diabetes $NVO $LLY"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947012591382941798) 2025-07-20 19:15:50 UTC 4962 followers, XX engagements "Sanofis Phase X Study on SAR444656: A Potential Game-Changer for Hidradenitis Suppurativa $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944169582748373371) 2025-07-12 22:58:44 UTC 4964 followers, XXX engagements "🦉 Younger people are picking up GLP-1s faster but those under XX still lean more toward surgery. Only a tiny fraction who start GLP-1s end up getting surgery showing most stick to one route. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946221972150517975) 2025-07-18 14:54:11 UTC 4967 followers, XXX engagements "🦉 Blunted response in DM group may stem from: 1) insulin resistance 2) chronic hyperinsulinemia 3) glycemic control reducing glycosuriadiminishing net energy loss. #diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946983161310654624) 2025-07-20 17:18:53 UTC 4964 followers, XXX engagements "💼Targeted in vivo gene integration of a secretion-enabled GLP-1 receptor agonist reverses diet-induced non-genetic obesity and pre-diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944474956659577099) 2025-07-13 19:12:10 UTC 4954 followers, XXX engagements "💼Comparative effectiveness of GLP-1 receptor agonists on glycaemic control body weight and lipid profile for type X diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946592280942375206) 2025-07-19 15:25:40 UTC 4954 followers, XXX engagements "🦉 Yessex matters in both effect and side effects. Women respond to GLP-1 analogs with stronger weight loss and food craving suppression amplified by estrogen's synergy with GLP-1 signaling. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #sex"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945881959340663251) 2025-07-17 16:23:06 UTC 4956 followers, XXX engagements "$REGN $REPL $GSK $ASND $APLS $PTCT $REGN $KALV 🌐💲"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1940787537897050520) 2025-07-03 14:59:41 UTC 4965 followers, XXX engagements "$NBND $NWBO $AVXL $LWLG $EMED $AMRN $MVNT $COOP $HALO $SFWJ $BMXI $RDAR $VPLM $NLST $TGLO 🌐"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945958916543684723) 2025-07-17 21:28:54 UTC 4966 followers, XX engagements "Obesity Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment DelveInsight $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945890174031876268) 2025-07-17 16:55:45 UTC 4965 followers, XXX engagements "💼Sai Life Sciences exec: GLP-1 boom has exploded the peptide field as firm opens new center $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945614601359393100) 2025-07-16 22:40:43 UTC 4964 followers, XXX engagements "GLP-1 drug akin to Ozempic showed no benefits for Parkinsons disease $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946240304513773577) 2025-07-18 16:07:02 UTC 4966 followers, XXX engagements "🦉 Semaglutide must drop XX% and tirzepatide XX% to meet the $100K/QALY threshold. Current cost: $700$800/month. Even under optimal health gains both remain economically inefficient. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944819687780470891) 2025-07-14 18:02:01 UTC 4963 followers, XXX engagements "🦉 Among 6392 patients in a weight-loss program XXXX% had GLP-1 treatment interruptionsyet still averaged XXXX% weight loss in a year. Even minimal exposure led to meaningful results. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946286545297703423) 2025-07-18 19:10:47 UTC 4968 followers, XXX engagements "GLP1-RA and SGLT2-i: Implementation and Insulin Deescalation Strategies $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944171344473526279) 2025-07-12 23:05:44 UTC 4962 followers, XXX engagements "💼Eli Lillys New Study on LY4065967: Key Insights for Investors $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946006830263476425) 2025-07-18 00:39:18 UTC 4963 followers, XXX engagements "🦉 No between-group difference in VAT decrease with liraglutide but G2 improved glucose by XXXX mmol/L (p = 0.002) vs. XXXX mmol/L in G1 (p = 0.002). Consistent effect in T2D subgroup. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1947021476500025773) 2025-07-20 19:51:08 UTC 4964 followers, XX engagements "💼Activation of GLP-1 receptors enhances the osteogenic differentiation process of STRO-1-positive BMSCs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946674107958882492) 2025-07-19 20:50:49 UTC 4954 followers, XXX engagements "🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists Head-to-head trials directly comparing tirzepatide vs. semaglutide or exenatide remain absent. Agent selection remains data-limited. #GLP1 #trialgap $LLY $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946939520340906411) 2025-07-20 14:25:28 UTC 4962 followers, XXX engagements "SK bioscience Sanofi receive approval for pneumococcal vaccine trials in China - CHOSUNBIZ $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946239961012842757) 2025-07-18 16:05:40 UTC 4966 followers, XXX engagements "Comparative effectiveness of combining antidiabetic medications to treat renal impairment in patients with type X diabetes mellitus $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945888596445069612) 2025-07-17 16:49:28 UTC 4963 followers, XXX engagements "💼Head-to-head Study Shows Bariatric Surgery Superior to GLP-1 Drugs for Weight Loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1944469318642946345) 2025-07-13 18:49:46 UTC 4964 followers, XXX engagements "🦉 Next-gen therapies promise more than weight loss muscle preservation fewer side effects and lasting results via gene editing or combo molecules. Thats the gap today's meds still cant fill. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945879591664435346) 2025-07-17 16:13:42 UTC 4956 followers, XXX engagements "Emcure Pharma shares rise X% on deal to distribute Sanofi India's oral anti-diabetic products $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945889117637648783) 2025-07-17 16:51:33 UTC 4964 followers, XXX engagements "🦉 At XX months XXXX% of women and XXXX% of men on oral semaglutide reached HbA1c 7%. No significant sex difference in glycaemic control dose persistence or side effect profile. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX"  [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946994490641711183) 2025-07-20 18:03:54 UTC 4954 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AponiaAnalytics aponia_analytics
aponia_analytics posts on X about $lly, $nvo, $azn, $sny the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXXX +127%
- X Month XXXXXXX +32%
- X Months XXXXXXX +604%
Mentions: XXX #
- X Week XXX +38%
- X Month XXXXX +7.60%
- X Months XXXXX +440%
Followers: XXXXX #
- X Week XXXXX +0.53%
- X Month XXXXX +1.80%
- X Months XXXXX +109%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXXX% currencies #1098 cryptocurrencies XXXX% finance XXXX% countries XXXX% technology brands XXXX% social networks XXXX% exchanges XXXX% celebrities XXXX% travel destinations XXXX%
Social topic influence $lly #1, $nvo #3, $azn #3, $sny #2, $gsk #1, $pfe #10, pfe #1, $rhhby #1, $vktx #3, $zldpf #1
Top accounts mentioned or mentioned by @icldc @cidrap @alphavestcap @glptrackerapp @thenci @thencis @varrell @elguapotron4000 @fda @who @usfda @drmakaryfda @drsamuelbhume @ltbioinvestor @mrmikeinvesting @timopler @caitpollpoll @capitaljc @coachnickmoney @spartatrades
Top assets mentioned Eli Lilly and Company (LLY) Novo-Nordisk (NVO) AstraZeneca PLC (AZN) Synthetify (SNY) GSK plc (GSK) Pfizer, Inc. (PFE) Viking Therapeutics, Inc (VKTX) Hims & Hers Health, Inc. (HIMS) Sanofi (SNY) Coop Coin (COOP) Viking Holdings Ltd (VIK) Bitcoin Incognito (XBI) SPDR S&P XXX ETF Trust (SPY) Merck & Co., Inc. (MRK) Sarepta Therapeutics, Inc. (SRPT) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) CRISPR Therapeutics AG (CRSP) SuperRare (RARE) MicroCloud Hologram Inc. (HOLO) LM Funding America, Inc. (LMFA) Regeneron Pharmaceuticals Inc (REGN) ritestream (RITE) Biogen Inc (BIIB) Eos Energy Enterprises, Inc. (EOSE) Soleno Therapeutics, Inc. Common Stock (SLNO) Oscar Health, Inc. (OSCR) PTC Therapeutics, Inc. (PTCT) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)
Top Social Posts #
Top posts by engagements in the last XX hours
"Type X Diabetes Market Exclusive Report with Detailed Study $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-18 16:11:54 UTC 4966 followers, XXX engagements
"Sanofi completes $XXX billion acquisition of Blueprint Medicines Nasdaq delisting follows $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:04:49 UTC 4964 followers, XXX engagements
"🦉 G2 participants had higher baseline glucose (median XXXX mmol/L) and A1c (7.6%) than G1 (5.5 mmol/L 5.9%). Despite this they achieved larger absolute reductions over the study period. #diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 19:54:16 UTC 4963 followers, XX engagements
"Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:46:12 UTC 4965 followers, XXX engagements
"💼Tirzepatide plus hormone therapy boosts weight loss in menopausal women $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide" @AponiaAnalytics on X 2025-07-18 22:15:35 UTC 4965 followers, XXX engagements
"🦉 Contraindications: Personal/family history of MTC or MEN2 rules out GLP-1 RA use. No routine thyroid monitoring required. FDA cites theoretical cancer risk but no human trial evidence confirms it. #GLP1 #safety $NVO $LLY $AZN $SNY $VKTX $GSK $PFE" @AponiaAnalytics on X 2025-07-20 21:33:21 UTC 4954 followers, XXX engagements
"$REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX 🌐" @AponiaAnalytics on X 2025-07-19 19:31:17 UTC 4954 followers, XX engagements
"Hims & Hers Health Inc. (HIMS) Alleged Deceptive $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:09:19 UTC 4966 followers, XXX engagements
"🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists GI side effectsprimarily nausea and diarrheawere the most frequent across agents. Gradual dose titration and combo therapy improved tolerability. #GLP1 $PFE $AZN" @AponiaAnalytics on X 2025-07-20 14:24:07 UTC 4962 followers, XX engagements
"$LIXT $THTX $CLRB $OSTX $VRTX $ELAN $OGEN $NVS $FDMT $DYN $NKTR $IMAB $BCAB $INO" @AponiaAnalytics on X 2025-07-03 15:59:06 UTC 4966 followers, XXX engagements
"$MRK 💼Merck to Acquire Verona Pharma Expanding its Portfolio to Include Ohtuvayre (ensifentrine) a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade" @AponiaAnalytics on X 2025-07-09 20:30:52 UTC 4967 followers, XXX engagements
"💼Are GLP-1 drugs worth their current cost $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-14 18:02:00 UTC 4954 followers, XXX engagements
"🦉 Bone mineral density (BMD) declines with rapid calorie restriction10% weight loss = XXX% lumbar/hip BMD loss. GLP-1RAs may mitigate this via enhanced Runx2 ALP Col1A1 expression in osteoblasts. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 20:08:29 UTC 4963 followers, XX engagements
"🦉 Liraglutide reduced thigh muscle fat by XXXX% in XXXX% of patients vs. XXXX% in XXXX% on placebo. Z-score of muscle volume unchanged. MRI confirms structural remodeling without hypertrophy. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 20:07:57 UTC 4954 followers, XXX engagements
"Hims & Hers Health Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy Triggers Securities Class Actions - HIMS Investors with Losses Encouraged to Contact Hagens Berman $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:45:49 UTC 4956 followers, XXX engagements
"🦉 XX% of PCOS patients in a survey (n=1700) using GLP-1s reported more predictable periods; XX% had shorter bleeding days. Indicates hormonal impact beyond weight reduction. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 16:00:00 UTC 4964 followers, XXX engagements
"💼Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GIP #GLP1" @AponiaAnalytics on X 2025-07-18 14:37:49 UTC 4954 followers, XXX engagements
"🦉 Liraglutide (Victoza Saxenda): daily injection. Semaglutide (Ozempic Wegovy Rybelsus): weekly or oral. Dulaglutide (Trulicity): weekly. All deliver durable GLP-1 signaling for metabolic control. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 15:31:18 UTC 4954 followers, XXX engagements
"This week in X numbers: Nearly a quarter of companies offer GLP-1 drug coverage for weight management $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:04:22 UTC 4962 followers, XXX engagements
"🦉 Predictors of success: HbA1c X% (aOR: XXX at X months; XXXX at XX months). Impairing factors: age XX (aOR: XXXX and 0.41) and primary care prescriptions (aOR: XXXX at X months). #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 18:03:27 UTC 4962 followers, XXX engagements
"Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisks Weight Loss Drug Patent Expires $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:09:46 UTC 4964 followers, XXX engagements
"Thermo Fisher and Sanofi Expand Strategic Partnership to Enable US Drug Manufacturing $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:05:27 UTC 4966 followers, XXX engagements
"Thermo Fisher acquires Sanofis steriles manufacturing site in US $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:49:11 UTC 4964 followers, XXX engagements
"Sanofi Into-Sana medical center network announce strategic partnership $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:04:28 UTC 4966 followers, XXX engagements
"Menopausal hormone therapy may boost weight loss seen with Zepbound $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:39:51 UTC 4960 followers, XXX engagements
"🦉Tirzepatide cut apnea events by up to XX per hour and heart failure complications by 38%. GLP-1 drugs also lowered CRP IL-6 and TNF-key markers of systemic inflammation. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-18 14:43:11 UTC 4964 followers, XXX engagements
"💼Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1" @AponiaAnalytics on X 2025-07-17 19:45:04 UTC 4965 followers, XXX engagements
"$QTTB 🌐 $SGN $FTFT $INKT $CVM $ZBAI $LMFA $HOLO $CAPR $FAAS $NVVE $SPY" @AponiaAnalytics on X 2025-07-11 13:49:27 UTC 4965 followers, XXX engagements
"Sanofi Appoints Rachid Ayari as Interim MD Inks Distribution Deal with Emcure $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIM" @AponiaAnalytics on X 2025-07-17 16:58:26 UTC 4965 followers, XXX engagements
"🦉 XXXX% of women on oral semaglutide lost XX% of body weight within X months; that proportion more than doubled to XXXX% at XX months. Median weight loss at XX months: XXX% XXX to XXXX. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 18:02:46 UTC 4963 followers, XX engagements
"🦉 Eli Lilly is testing LY4065967 in a Phase X trial focused on how the drug behaves inside the bodyabsorption breakdown and elimination. It uses a radiolabeled version to track every move. Two dosing formats reveal how much actually gets used. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 00:39:18 UTC 4967 followers, XXX engagements
"$CAPR 🌐 $SGN $FTFT $INKT $CVM $ZBAI $LMFA $HOLO $CAPR $FAAS $QTTB $SPY" @AponiaAnalytics on X 2025-07-11 13:48:18 UTC 4965 followers, XXX engagements
"How to sell Novo Nordisk tokenized stock (xStock) (NVOX) via a crypto wallet $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-03 16:07:21 UTC 4963 followers, XXX engagements
"🦉 Clinical trials: Liraglutide preserved cortical bone mass during weight loss. Systematic review (25 studies): GLP-1RAs increased BMD at lumbar spine/femoral neck in T2DM XX years. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 20:09:57 UTC 4954 followers, XXX engagements
"GPs swamped by requests for NHS Mounjaro but hardly anyone qualifies $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:11:07 UTC 4964 followers, XXX engagements
"🦉 Two-year data from over 51000 patients showed bariatric surgery led to XX% weight loss versus just XXX% for GLP-1 users. Even full-year GLP-1 adherence only reached X% far below trial results of 1521%. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 18:49:49 UTC 4965 followers, XXX engagements
"🦉 Despite efficacy semaglutide discontinuation leads to weight regainSTEP X extension and STEP X confirm relapse within X year. Long-term therapy is necessary. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 17:21:59 UTC 4964 followers, XXX engagements
"🦉 In the Swedish dataset semaglutide and liraglutide users also had fewer hospitalizations for substance use disorders and somatic conditionsexenatide did not replicate these results. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 21:12:03 UTC 4954 followers, XXX engagements
"💼Health Rounds: GLP-1 obesity drugs may boost low testosterone $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #testosterone" @AponiaAnalytics on X 2025-07-16 21:55:54 UTC 4962 followers, XXX engagements
"💼Cancer Risk Concerns and Communication Gaps Regarding GLP-1 Medications $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 15:00:25 UTC 4964 followers, XXX engagements
"🦉 GLP-1 boosts skeletal muscle glycogen synthesis through AMPK and PI3K/AKT signaling. But in T2DM defective AKT impairs this pathway. Exendin-4 increased glycogen synthase-a and GLUT4 in human myocytes. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK" @AponiaAnalytics on X 2025-07-20 19:31:08 UTC 4962 followers, XX engagements
"🦉 GLP-1 drugs reach deeper brain areas over time modulating hunger without activating all nausea circuits. Their impact depends on brain access vagal nerve input and how each person's biology responds to the signal. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-17 18:13:41 UTC 4964 followers, XXX engagements
"💼Daniel Drucker Ozempics father: Im very conservative. I dont sell the drugs. I study the drugs The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However he remains cautious about their use $NVO" @AponiaAnalytics on X 2025-07-20 16:36:52 UTC 4963 followers, XX engagements
"💼A new era of weight loss: Mental health effects of GLP-1 drugs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #psychology" @AponiaAnalytics on X 2025-07-13 18:45:00 UTC 4968 followers, XXX engagements
"🦉 No difference in weight loss by sex: XXX% in women vs XXX% in men at XX months (p = 0.73). Similarly discontinuation (23.7% vs. 22.7%) and AEs (2.5% vs. 1.4%) were not sex dependent. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 18:05:11 UTC 4965 followers, XX engagements
"Lillys orforglipron and other key catalysts set to reshape drug landscape $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:07:52 UTC 4962 followers, XXX engagements
"Viking Therapeutics to Report Financial Results for Second Quart $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:41:55 UTC 4965 followers, XXX engagements
"Fans Defend Serena Williams After Her New Gym Selfies Spark Ozempic Accusations $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS$NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:53:22 UTC 4952 followers, XXX engagements
"🦉 XX trials included: STEP XX XX HFpEF HFpEF-DM. Intervention: semaglutide XXX mg weekly for 4468 weeks. Study populations ranged from XXX to 1900 participants. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 17:18:36 UTC 4954 followers, XXX engagements
"🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists All six RCTs used treatment durations XX weeks. GLP-1 RAs showed sustained weight loss and metabolic improvements across diabetic and non-diabetic cohorts. #GLP1 #RCT $NVO $LLY" @AponiaAnalytics on X 2025-07-20 14:22:42 UTC 4962 followers, XX engagements
"🦉Semaglutide reduced major cardiovascular events by XX% kidney failure risk by XX% and resolved liver inflammation in XX% of MASH cases. Benefits occurred even with limited weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-18 14:43:11 UTC 4966 followers, XXX engagements
"🦉 A non-peer-reviewed report falsely inflating mifepristones risk profile is reshaping political pressure on the FDA exposing biotech to arbitrary disruption and threatening investor confidence. #biotech #regulation" @AponiaAnalytics on X 2025-07-19 19:52:21 UTC 4963 followers, XX engagements
"🦉 XX of XXX social media posts (10%) contained false claims. These included unproven uses underreported ADRs and complete absence of indication info. All platforms showed misinformation not just users. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK" @AponiaAnalytics on X 2025-07-20 16:21:41 UTC 4964 followers, XX engagements
"💼The Future of GLP-1s in Type X Diabetes with Viral Shah MD $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1" @AponiaAnalytics on X 2025-07-18 19:03:40 UTC 4967 followers, XXX engagements
"$BDPT 🌐 $NWBO $LWLG $GTCH $FNMA $NB $ELTP $RDGL $HMBL $COOP" @AponiaAnalytics on X 2025-07-16 17:31:29 UTC 4967 followers, 1089 engagements
"🦉 Tirzepatide caused more GI issues in trials but delivered stronger weight loss while exenatide had higher nausea and injection site reactions. Liraglutide ranks worst for early nausea at 40%. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 15:04:42 UTC 4964 followers, XXX engagements
"🦉 In the BELIEVE trial (n=507) bimagrumab + semaglutide achieved XXXX% total weight loss surpassing semaglutide alone (15.7%). Fat loss made up XXXX% of the drop minimizing lean mass lossa key advance in therapy. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 18:55:41 UTC 4964 followers, XXX engagements
"🦉 Tirzepatide activates both GIP and GLP-1 receptors. Early data shows superior glucose and weight loss outcomes vs. semaglutide. Triple agonists targeting GLP-1/GIP/glucagon are under development. #Tirzepatide #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 15:32:32 UTC 4955 followers, XXX engagements
"$APLS $ALPMY $OCUL $EYPT $REGN $SRZN $RHHBY $APLS $ALPMY 🌐" @AponiaAnalytics on X 2025-07-10 23:53:50 UTC 4967 followers, XXX engagements
"💼The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-17 17:36:43 UTC 4963 followers, XXX engagements
"Impact of Glucagon-Like Peptide-1 Receptor Agonists on Postoperative Outcomes in Arthroplasty: A Systematic Review $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:06:20 UTC 4966 followers, XXX engagements
"🦉 XX% increase in ankle-brachial index and improved walking distance in PAD patients treated with semaglutide (STRIDE trial). No quality of life change noted but perfusion and mobility metrics improved. #Semaglutide #PAD $NVO $LLY $AZN $SNY $VKTX $GSK" @AponiaAnalytics on X 2025-07-20 21:27:00 UTC 4954 followers, XXX engagements
"💼The expanding benefits of GLP-1 medicines $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-18 14:43:10 UTC 4954 followers, XXX engagements
"🦉 GLP-1 enhances hepatic glycogen synthesis via insulin-dependent and insulin-independent mechanisms involving AKT AMPK PI3K PKC and PP-1 signaling. GLP-1-deficient mice show reduced liver glycogen and glucose tolerance. #GLP1 #diabetes $NVO $LLY" @AponiaAnalytics on X 2025-07-20 19:30:39 UTC 4955 followers, XX engagements
"🦉 In postmenopausal women combining tirzepatide with hormone therapy led to a XX% weight drop3 points higher than with tirzepatide alone. Over XX% hit more than XX% total weight loss with the combo versus just XX% without. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide" @AponiaAnalytics on X 2025-07-18 22:15:36 UTC 4968 followers, XXX engagements
"$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label" @AponiaAnalytics on X 2025-07-16 21:04:02 UTC 4965 followers, XXX engagements
"Retrospective analyses indicate Ozempics protective effects against stroke fatality $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:06:08 UTC 4966 followers, XXX engagements
"🦉 Large-scale study (40k patients): semaglutide reduced periprosthetic infections sepsis and readmissions after knee arthroplasty. Yet increased MI AKI pneumonia also observed. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 20:41:38 UTC 4954 followers, XXX engagements
"🦉 Bioimpedance: No significant change in VAT SAT or muscle mass in either group after X months. Despite weight loss and glycemic gains VAT reduction not statistically different. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 19:52:35 UTC 4954 followers, XXX engagements
"$APGO $HMBL $DTREF $GTCH $SAPX $IGPK $ENTA $AFFU $TWOH $RITE $ADHC $FITY $CYBL $GTCH $NWBO $FNMA $ELTP $AVXL $PSRU $COOP $AFFU $CGAC $PSWW" @AponiaAnalytics on X 2025-07-18 17:29:29 UTC 4952 followers, XX engagements
"🦉 Liraglutide and semaglutide delay gastric emptying. Tirzepatide mimics this but effect fades. Still dose-escalation preserved delay in T2DM patients unlike constant exposure. #Semaglutide #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 19:33:51 UTC 4954 followers, XX engagements
"🦉 Use of SGLT2i lower in women than men (50.2% vs. XXXX% p 0.001). In women with CKD use was XXXX% vs. XXXX% in men (p = 0.04) suggesting a sex-based treatment gap in nephroprotection. #diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 18:06:05 UTC 4965 followers, XX engagements
"🦉 In a 7-year cohort of 60860 adults with diabetes and obesity semaglutide and tirzepatide use was linked to a XX% lower dementia risk and XX% lower mortality. Stroke risk also dropped XX% with stronger effects in women and seniors. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-18 22:12:09 UTC 4968 followers, XXX engagements
"🦉 XX% of participants in STEP trials reported GI disorders with XXX mg semaglutide weekly. Yet on Instagram these AEs were mentioned in X% of postsdespite being the most common reaction. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 16:16:37 UTC 4965 followers, XX engagements
"🦉 In XXX men (avg. age 54) treated with semaglutide dulaglutide or tirzepatide for XX months normal testosterone rates rose from XX% to 77%. Greater weight loss was linked to larger hormonal gains. Drugs used: #Ozempic #Wegovy #Trulicity #Mounjaro #Zepbound" @AponiaAnalytics on X 2025-07-20 17:02:02 UTC 4955 followers, XXX engagements
"💼GLP-1 receptor agonist therapy improves cardiometabolic outcomes in adults with overweight or obesity: A meta-analysis $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 19:43:36 UTC 4964 followers, XXX engagements
"🦉 In the only randomized trial so far exenatide did not reduce heavy drinking overall. But in obese patients it significantly cut heavy drinking days and alcohol intake vs. placebo. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 21:09:53 UTC 4954 followers, XXX engagements
"🦉 Ozempic mentioned in XX% of posts; Wegovy in 18%; Rybelsusdespite FDA approvalonly 1%. Daily pill format and adherence challenges likely reduced its visibility. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 16:23:34 UTC 4954 followers, XXX engagements
"🦉 The Mayo Clinic study tracked XXX women and showed the dual therapy may also help curb heart and metabolic risks. The effect was more than additive suggesting hormone therapy amplifies tirzepatides weight-loss action. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide" @AponiaAnalytics on X 2025-07-18 22:15:37 UTC 4968 followers, XXX engagements
"🦉 G2 (OB + T2D) patients lost more weight over X months than G1 (OB + PD): XXXX kg (p = 0.012) vs. XXX kg (p = 0.000). G1 plateaued after X months; G2 showed sustained reduction. #weightloss #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 19:50:44 UTC 4954 followers, XXX engagements
"🦉 GLP-1 controls eating by acting on brainstem and hypothalamic circuits that sense gut signals and regulate fullness. These circuits reduce meal size delay gastric emptying and change food reward perception. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-17 18:13:41 UTC 4964 followers, XXX engagements
"🦉 Recent findings confirm GLP-1 RAs not only reduce atherosclerosis but also restore mitochondrial dynamics by inhibiting Drp-1-driven fission and activating AMPK2. These changes reshape energy metabolism in diabetic hearts. #GLP1 #cardiovascular" @AponiaAnalytics on X 2025-07-18 19:51:08 UTC 4967 followers, XX engagements
"🦉 Twelve percent of U.S. adults have used GLP-1 agonists like semaglutide or tirzepatide. A new 6-month University of Melbourne trial will use MRIs to evaluate brain changes in adults with BED taking GLP-1s. All subjects receive concurrent psychotherapy. GLP-1s are not yet approved for BED. #GLP1 #Tirzepatide $NVO $LLY" @AponiaAnalytics on X 2025-07-20 16:57:24 UTC 4965 followers, XX engagements
"🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists Liraglutide XXX mg/day (Jensen 2022) preserved appetite control and improved cognitive restraint and sedentary time over XX weeks. #liraglutide $NVO $HIMS" @AponiaAnalytics on X 2025-07-20 14:22:18 UTC 4963 followers, XX engagements
"$PRAX $NBIX $BHVN $XENE $AQST $BIIB $DNLI $JAZZ $UCBJF 🌐" @AponiaAnalytics on X 2025-07-10 23:54:55 UTC 4968 followers, XXX engagements
"🦉 GLP-1 receptor agonists extend activity far beyond the natural hormones few-minute lifespan. Engineered to resist DPP-4 they remain active from several hours to X daysamplifying satiety and reducing caloric intake. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 15:24:50 UTC 4955 followers, XXX engagements
"💼Which GLP-1 Has the Least Side Effects $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 15:04:41 UTC 4965 followers, XXX engagements
"🦉 Brain scans showed weaker responses to high-fat high-sugar foods revealing tirzepatides unique action on both GLP-1 and GIP pathways. The effect outperformed liraglutide and didnt rely on willpower. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide" @AponiaAnalytics on X 2025-07-18 22:17:52 UTC 4963 followers, XXX engagements
"💼Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-18 22:12:08 UTC 4968 followers, XXX engagements
"💼A sloppy report on mifepristone is being used to undermine the FDA and the biotech industry #biotech #regulation" @AponiaAnalytics on X 2025-07-19 19:52:20 UTC 4963 followers, XX engagements
"🦉 Startups face direct liability as compounded GLP-1s bypass clinical trials lack consistency and trigger legal action over safety mislabeling and unfair competition. Investor trust is eroding fast. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-16 22:47:41 UTC 4968 followers, XXX engagements
"Sanofi India appoints Rachid Ayari as Interim MD $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:50:39 UTC 4964 followers, XXX engagements
"💼The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-16 22:47:40 UTC 4968 followers, XXX engagements
"🦉 Oral semaglutide reduced systolic BP by X mmHg after both X and XX months. In parallel XXXX% of women achieved HbA1c XXX% at XX monthsnearly identical to XXXX% in men. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 18:07:07 UTC 4962 followers, XXX engagements
"$VKTX Viking is nearing key Phase X results for VK2735 its oral weight-loss drug tested in XXX adults with obesity-related conditions. Earlier data showed up to XXX% weight loss in just four weeks. If the 13-week results confirm strong and safe effects VKTX could gain ground in the massive obesity drug race" @AponiaAnalytics on X 2025-07-10 22:09:33 UTC 4962 followers, 1046 engagements
"$EOSE 💼Industrial Services stocks outperformed the S&P XXX (+16.5% YoY vs 11.2%) trading at a premium 30.7x EV/EBITDA. Siemens grows software TAM by $11B via AI-driven acquisitions. Eos Energy eyes a XXX% revenue jump in 2025 on X GWh battery ramp-up. MSC Industrial targets IP Index +400bps with U.S. expansion. Sector backed by rising MRO e-commerce (18.9% global CAGR). #EosEnergy #Siemens $SIE" @AponiaAnalytics on X 2025-07-10 12:52:31 UTC 4964 followers, XXX engagements
"$NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-17 16:16:50 UTC 4956 followers, XXX engagements
"🦉 GLP-1 recalibrates food perception by acting on the hypothalamus and reward centersdecreasing both physical hunger and hedonic craving. This dual effect makes it uniquely potent for weight regulation. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 15:30:49 UTC 4965 followers, XX engagements
"🦉 Liraglutide preserved GLP-1R expression in osteoarthritic cartilage enhanced PKA/CREB signaling and decreased NF-B translocation. Mechanistic evidence for anti-catabolic cartilage effect. #GLP1 #arthritis $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 20:42:25 UTC 4954 followers, XXX engagements
"💼Beyond a singular focus on GLP-1: why we need a new nomenclature now $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-17 16:16:49 UTC 4968 followers, XXX engagements
"Novo Nordisk: Company Did Not Report or Investigate Deaths Potentially Caused by Ozempic $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:50:15 UTC 4960 followers, XXX engagements
"🦉 For weight loss CagriSema ranked highest with XXXXX kg followed by tirzepatide and retatrutide. Adverse events rose with dose notably GI issues making tolerability a key factor. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes" @AponiaAnalytics on X 2025-07-19 15:25:41 UTC 4964 followers, XXX engagements
"🦉 But they also experience more nausea anxiety and treatment dropout. Despite this females remain underrepresented in trials leaving gaps in understanding how these drugs work across sexes. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #sex" @AponiaAnalytics on X 2025-07-17 16:23:07 UTC 4956 followers, XXX engagements
"💼Experimental flu drug may protect better than flu vaccines company data show #vaccine $CDTX #Cidara @CIDRAP" @AponiaAnalytics on X 2025-07-08 23:57:30 UTC 4964 followers, 1011 engagements
"$SRPT $RCKT $MBRX $DMAC $MAIA $AGEN $XXII $DNA $SDGR $PRAX $CYBN $NKGN $HROW $ALDX $BMY $RDNT $ACTU $TXG $IMAB $NLSP $KROS $AZN $JNJ $BCAB $SXTP $SXTP $OKYO $STXS $LSTA $CLSD $SRPT 🌐" @AponiaAnalytics on X 2025-07-17 16:42:54 UTC 4954 followers, 1475 engagements
"🦉 PCOS affects XX million U.S. women. 3580% are insulin resistant. No standard treatment exists; birth control Metformin and lifestyle changes address symptoms partially. GLP-1s offer new metabolic leverage. #PCOS #GLP1 $NVO $LLY $AZN $SNY $GSK" @AponiaAnalytics on X 2025-07-20 16:03:03 UTC 4963 followers, XX engagements
"$BULT $NWBO $HMBL $DTREF $GTCH $SAPX $IGPK $ENTA $AFFU $TWOH $RITE $ADHC $FITY $CYBL $GTCH $FNMA $ELTP $AVXL $PSRU $COOP $AFFU $CGAC $PSWW" @AponiaAnalytics on X 2025-07-17 17:10:27 UTC 4962 followers, XX engagements
"🦉 YesGLP-1R agonists protect the brain after stroke reduce liver fat in NAFLD slow kidney disease and ease neurodegeneration. They also lower substance use and aid organ transplant survival. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-17 17:36:44 UTC 4964 followers, XXX engagements
"$DWTX $TC $JG $TCTM $ONCO $NVNI $ETNB $HOLO $MLGO $HWH 🌐" @AponiaAnalytics on X 2025-07-03 15:18:02 UTC 4966 followers, XXX engagements
"Incretin-based approaches for type X diabetes therapy: effects on circulating cytokines and adipocyte's secretome $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:05:10 UTC 4966 followers, XXX engagements
"🦉 In a trial of XXX obese patients with knee OA semaglutide reduced both weight and pain. Liraglutide in contrast had no pain benefit despite weight loss. Drug-specific OA effects likely. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 20:42:02 UTC 4954 followers, XXX engagements
"🦉 In Qeadan et al.s dataset of 800000+ adults with AUD GIP/GLP-1 agonists were associated with a XX% reduction in alcohol intoxication rates. This held true when stratified by both obesity and diabetes status. #GLP1 #Tirzepatide $NVO $LLY $AZN" @AponiaAnalytics on X 2025-07-20 21:09:04 UTC 4954 followers, XX engagements
"🦉 Tirzepatide led glycaemic control with a XXXX% HbA1c drop and XXXX mmol/L fasting glucose outperforming XX other GLP-1RAs. Its dose-efficacy was linear peaking at XX mg weekly. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes" @AponiaAnalytics on X 2025-07-19 15:25:41 UTC 4965 followers, XXX engagements
"Sanofi and EQT invest XXX million in SpliceBio to advance gene therapy $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 22:56:38 UTC 4965 followers, XXX engagements
"🦉 Up to XX% of total weight loss from semaglutide and XX% from tirzepatide derives from lean body mass. Yet extremity muscle % remained stable and handgrip strength unchanged after X months. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 20:07:28 UTC 4954 followers, XXX engagements
"🦉 Semaglutide was tied to fewer dementia cases while tirzepatide showed stronger results in stroke prevention and survival. Neither drug affected Parkinsons or brain bleeds pointing to a more targeted brain and vessel benefit. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-18 22:12:09 UTC 4968 followers, XXX engagements
"Emcure Sanofi tie up for anti-diabetic range $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:39:18 UTC 4960 followers, XXX engagements
"$NWBO NWBOs long-standing partnership with Cognate wasnt just strategicit was foundational. More than 2300 personalized DCVax-L doses were manufactured under full GMP making it one of the largest autologous immunotherapy trials ever run. When Charles River paid $875M to acquire Cognateover 11x revenueit effectively validated the manufacturing platform NWBO had quietly built. Add to that: DCVax-L lots remain viable after X years in cryostorage a rarity in cell therapy. Thats not typical. Thats moat" @AponiaAnalytics on X 2025-07-06 12:31:39 UTC 4960 followers, 1524 engagements
"🦉 Participants with no access issues lost more weight but those with just XX doses still dropped over 10%. Coaching and structured lifestyle changes helped soften the impact of missed meds. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-18 19:10:47 UTC 4967 followers, XXX engagements
"🦉 Even without official approval more patients are trying GLP-1s for T1D. The spotlight is finally shifting from insulin alone to newer longer-acting and smarter treatments that could change the game. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1" @AponiaAnalytics on X 2025-07-18 19:03:41 UTC 4968 followers, XXX engagements
"$NCNA $HCTI $SPZI $PNPN $CNRC $SAGMF $CFTN $ADHC $TWOH $CBRA $EHVVF 🌐" @AponiaAnalytics on X 2025-07-16 19:25:21 UTC 4965 followers, XX engagements
"🦉Body volume loss was sexually dimorphic: XX% of lost volume in men came from the trunk vs. XX% in women; women lost more from legs. BRI visualizations confirmed high baseline risk and partial normalization. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GIP #GLP1" @AponiaAnalytics on X 2025-07-18 14:37:51 UTC 4964 followers, XXX engagements
"🦉 GLP-1 agonists showed sustained protective effect on AUD over X years in long-term users. Duration-based data is rare in addiction pharmacotherapy studies highlighting this as a key finding. #GLP1 #Tirzepatide $NVO $LLY $VKTX $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 21:12:39 UTC 4954 followers, XXX engagements
"Regeneron and Sanofis Phase X Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:12:06 UTC 4966 followers, XXX engagements
"🦉 In people with obesity or type X diabetes gut cells produce less GLP-1 weakening both glucose control and immune defenses in the gut. Chronic inflammation and high-fat diets worsen this decline especially as people age. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GLP1R" @AponiaAnalytics on X 2025-07-17 17:48:59 UTC 4965 followers, XXX engagements
"🦉 Demographics: Mean BMI was XXXX (non-DM) vs XXXX (DM); age XXXX vs XXXX years; XXXX% vs XXXX% female. These differences likely influenced treatment responsiveness. #obesity #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 17:19:07 UTC 4964 followers, XXX engagements
"🦉 REWIND showed dulaglutide reduced MACE in lower-risk T2DM patients; benefits driven by nonfatal stroke. But XX% discontinued by study end. Tolerability remains a limiting factor in long-term outcomes. #GLP1 #stroke $NVO $LLY $ZLDPF $VANI $HIMS $AZN" @AponiaAnalytics on X 2025-07-20 21:27:43 UTC 4954 followers, XXX engagements
"🦉 Weekly titration to XXX mg liraglutide: XXXXX% reached target by week 3; XXXX% by week X. Suggests most patients tolerate standard escalation despite known GI side effects. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 19:55:07 UTC 4954 followers, XXX engagements
"Hengrui Pharmas Potential Rival to El Lillys Zepbound Leads to XX% Weight Loss in Key Study $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:51:53 UTC 4960 followers, XXX engagements
"🦉3D avatars built from Surmount-1 trial data show how tirzepatide reshaped male and female bodies after XX weeks. Men saw a BMI drop from XXXX to 30.8; women from XXXX to XXXX. Waistlines shrank by 1721 cm. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GIP #GLP1" @AponiaAnalytics on X 2025-07-18 14:37:50 UTC 4966 followers, XXX engagements
"🦉 Side effects in 27.8%: nausea (19.4%) diarrhea (27.8%) vomiting (8.3%) urticaria (5.5%). One exclusion: severe intolerance with Mallory-Weiss tear. GI side effects consistent with prior trials. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 19:53:00 UTC 4963 followers, XX engagements
"🦉 GLP-1 RA metabolites like GLP-1 (936) act independently of the receptor enhancing endothelial recovery post-ischemia via cGMP/NO release. This expands their cardioprotective reach beyond classical GLP-1 signaling. #GLP1 #cardiovascular" @AponiaAnalytics on X 2025-07-18 19:51:08 UTC 4967 followers, XX engagements
"💼GLP-1 and Its Analogs: Does Sex Matter $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #sex" @AponiaAnalytics on X 2025-07-17 16:23:06 UTC 4968 followers, XXX engagements
"🦉 XXXX% vs 11.57%: Weight loss difference between diabetic and non-diabetic groups receiving semaglutide XXX mg. A clinically and statistically significant gap (p 0.001). #weightloss #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI" @AponiaAnalytics on X 2025-07-20 17:17:25 UTC 4964 followers, XXX engagements
"💼Out of Shortage Into Controversy: The Fight Over GLP-1 Compounding $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 14:45:53 UTC 4964 followers, XXX engagements
"GLP-1 drug akin to Ozempic showed no benefits for Parkinsons disease $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:52:22 UTC 4965 followers, XXX engagements
"Wegovy and Mounjaro: HSCC launches weight loss jab inquiry $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:44:42 UTC 4956 followers, XXX engagements
"$capc $ltnc $wint $nwbo $dpls $btog $apm $etst $atvk $rakr $qind" @AponiaAnalytics on X 2025-07-17 17:13:25 UTC 4966 followers, 1679 engagements
"🦉 In SUSTAIN-10 semaglutide reduced HbA1c and weight more than liraglutide but had higher GI side effects. Tirzepatidedual GLP-1/GIP agonistshowed superior glycemic control in meta-analysis. #Semaglutide #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 19:31:36 UTC 4954 followers, XX engagements
"Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:04:00 UTC 4967 followers, XXX engagements
"🦉 The subcutaneous GLP-1/GIP agonist is now being evaluated beyond type X diabetes. A successful readout could widen its label and shift competitive dynamics in the diabetes treatment landscape. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide #GLP1" @AponiaAnalytics on X 2025-07-18 22:06:47 UTC 4968 followers, XXX engagements
"Bristol Myers Squibbs Reblozyl fails Phase X in anemia; Sanofi Blueprint deal closes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:03:13 UTC 4966 followers, XXX engagements
"Novo-Nordisk A/S Foundation establishes a quantum company Magne Computer will be based in Denmark. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:40:24 UTC 4963 followers, XXX engagements
"$NBND 🌐 $NWBO $AVXL $LWLG $EMED $AMRN $MVNT $COOP $HALO $SFWJ $BMXI $RDAR $VPLM $NLST $TGLO $RNVA $DRNK $FUNR" @AponiaAnalytics on X 2025-07-16 17:32:39 UTC 4966 followers, XX engagements
"$cycc $BLNE $CTOR $PCSA $Btog $onmd $cyn $pew $sbet $ndra $wff $XXII $gctk $bglc $atnf $ptnm $VLCN 🌐" @AponiaAnalytics on X 2025-07-17 20:34:01 UTC 4962 followers, XXX engagements
"🦉 In Crees PCOS trial X of XX semaglutide-treated women didnt lose XX% body weight. One lost none. Response variability mirrors obesity trial dataGLP-1s dont work equally for all phenotypes. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 16:04:00 UTC 4964 followers, XX engagements
"Biocon targets launch for generic Wegovy in India by 2027 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:43:08 UTC 4956 followers, XXX engagements
"Hims & Hers (HIMS) Faces Legal Storm Post Novo Nordisk Breakup $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:56:07 UTC 4964 followers, XXX engagements
"🦉 Facebook post claimed: Buying weight loss drugs just got easier. No prescription No problem. Violates Germanys HWG XX which restricts direct-to-consumer drug ads to certified medical personnel. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 16:26:42 UTC 4954 followers, XX engagements
"Sanofi secures FDA fast-track status for SAR446597 in GA $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:48:51 UTC 4964 followers, XXX engagements
"Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July XX 2025 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:46:48 UTC 4964 followers, XXX engagements
"🦉 In Dr. Melanie Crees trial on semaglutide for PCOS X of XX women (not on Metformin) lost over XX% of body weight after XX months. X reached normal testosterone levels; X reported more regular periods. #PCOS #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 15:58:34 UTC 4954 followers, XX engagements
"🦉 Legal battles intensify as Eli Lilly sues the FDA challenging peptide vs. biologic classifications while brand manufacturers flood compounders with cease-and-desist letters. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 14:45:55 UTC 4963 followers, XXX engagements
"$HCTI $GIBO $WLGS $NCNA $CGBS $GTI $GVH $TNFA $CHSN $OST $FOXO $DFLI $SISI $JYD $EVTV $ABP $ATCH $WCT $PTLE $HTCO $IXHL $NITO $DHAI $AIRE $ASBP $INTS $LPTX $XHLD $CYCU 🌐" @AponiaAnalytics on X 2025-07-14 17:26:48 UTC 4965 followers, XXX engagements
"$BDPT 🌐 $NWBO $LWLG $GTCH $FNMA $NB $ELTP $RDGL $HMBL $COOP" @AponiaAnalytics on X 2025-07-16 17:26:38 UTC 4967 followers, XXX engagements
"🦉 Eight GLP-1RAs approved for T2DM; two for obesity. Short-acting agents mainly slow gastric emptying; long-acting forms regulate both basal and postprandial glucose. Half-life affects efficacy. #GLP1 #diabetes $NVO $LLY $AZN $VKTX $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 19:33:29 UTC 4954 followers, XXX engagements
"🦉 A one-time liver-targeted gene edit made mice produce Exendin-4 on their own. Treated mice ate less gained XX% less weight and had insulin levels and HbA1c close to healthy controls for XX weekswithout injections. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #diabetes" @AponiaAnalytics on X 2025-07-13 19:12:11 UTC 4962 followers, XXX engagements
"🦉 In Wang et al.s retrospective cohort semaglutide use in obese patients was linked to a XX% lower risk of new AUD diagnosis and a XX% lower risk of recurrent AUD vs. naltrexone or topiramateboth approved AUD drugs. #GLP1 #Semaglutide $NVO $LLY $AZN" @AponiaAnalytics on X 2025-07-20 21:08:29 UTC 4954 followers, XXX engagements
"Ohio lawmakers push to restore state employee access to weight loss drugs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:06:38 UTC 4966 followers, XXX engagements
"💼Microdosing: how off-label use of weight loss jabs is spreading from US to UK $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #UK" @AponiaAnalytics on X 2025-07-13 19:32:07 UTC 4962 followers, XXX engagements
"$CAPR 🌐 $SGN $FTFT $INKT $ZBAI $LMFA $BTOG $ARBK $WLGS $TAOX $CAPR $SPY" @AponiaAnalytics on X 2025-07-11 13:26:42 UTC 4965 followers, XXX engagements
"💼GLP-1 Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 21:02:29 UTC 4954 followers, XXX engagements
"🦉 Tirzepatide adds GIP receptor activation lowering IL-5 and IL-13 in asthma and cutting apnea events by over 25/hour in obesity-related sleep apnea. Effects appear partly independent of weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1" @AponiaAnalytics on X 2025-07-17 19:45:05 UTC 4965 followers, XXX engagements
"Sanofi completes billion-dollar acquisition of Blueprint Medicines $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:03:49 UTC 4966 followers, XXX engagements
"🦉 Hamilton began semaglutide in Oct 2024 as part of a PCOS trial. Within X weeks: menstruation resumed. After XX months: lost XX lbs regrew hair reduced depression/anxiety. Diet/exercise were maintained throughout. #Semaglutide #PCOS $NVO $LLY $AZN" @AponiaAnalytics on X 2025-07-20 16:00:34 UTC 4963 followers, XX engagements
"🦉 Most frequent side effects: nausea vomiting diarrhea constipation abdominal pain. Rare risks: pancreatitis and gallstones. Contraindicated in MEN X and medullary thyroid carcinoma. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 15:33:42 UTC 4955 followers, XXX engagements
"🦉 YouTube had the highest average information score at 1.38/5; Instagram scored just XXXX. Despite high engagement visual-first platforms rarely mention drug mechanism ADRs or regulatory status. #Semaglutide #weightloss $NVO $LLY $AZN $SNY $GSK" @AponiaAnalytics on X 2025-07-20 16:21:12 UTC 4964 followers, XX engagements
"Hengrui Pharmas Potential Rival to El Lillys Zepbound Leads to XX% Weight Loss in Key Study #glp-1marketing #feedly $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-15 19:31:28 UTC 4963 followers, XXX engagements
"💼Lillys oral GLP-1 orforglipron showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines $LLY #GLP1 $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-14 18:16:40 UTC 4963 followers, XXX engagements
"🦉 In XXX women with T2D oral semaglutide reduced HbA1c by XXX% at X months and XXX% at XX months. Median weight loss reached XXX% at XX months; XXXX% achieved XX% weight reduction. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 18:00:58 UTC 4962 followers, XXX engagements
"🦉 Treatment mix: semaglutide weekly n=80; oral semaglutide n=20; liraglutide n=10; dulaglutide n=5. All treatment arms included in analysis. #Semaglutide #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:18:37 UTC 4954 followers, XXX engagements
"💼GIPR-Ab/GLP-1 peptideantibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-19 20:19:48 UTC 4963 followers, XXX engagements
"🦉 Effect sizes (Cohens d): waist circumference 1.01; triglycerides 0.53; HbA1c 0.51; final waist d=0.85; final BMI d=0.35; final HbA1c d=0.43. #obesity #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:20:25 UTC 4954 followers, XXX engagements
"🦉 No increased atrial fibrillation risk from GLP-1 RAs in a meta-analysis of XX RCTs. Separate semaglutide-specific data suggest possible AF reductionmechanism likely indirect via weight and inflammation. #GLP1 #AFib $NVO $LLY $AZN $SNY $VKTX $GSK" @AponiaAnalytics on X 2025-07-20 21:32:28 UTC 4954 followers, XXX engagements
"🦉 Three retrospective studies support GLP-1 efficacy in reducing: (1) AUD onset (2) AUD recurrence (3) intoxication events (4) hospitalizationsacross US and Nordic cohorts. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI" @AponiaAnalytics on X 2025-07-20 21:11:11 UTC 4954 followers, XXX engagements
"🦉 The weight loss effect of the GIPR-Ab/GLP-1 conjugate hinges on functional GIPR and GLP-1R in the brain not just in the periphery. Blocking GIPR in neurons amplified GLP-1R agonist efficacy. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-19 20:19:49 UTC 4954 followers, XXX engagements
"🦉 Female sex high baseline BMI and absence of diabetes are emerging predictors of superior response to semaglutide. Supports patient stratification in obesity care. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 17:21:28 UTC 4964 followers, XXX engagements
"GLP1 receptor agonist drug treatments and adult obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:49:49 UTC 4960 followers, XXX engagements
"🦉 CNS knockout of either receptor cut efficacy nearly in half even with intact peripheral signaling. The compound reached the brain via circumventricular organs and activated appetite-suppressing circuits. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-19 20:19:50 UTC 4964 followers, XXX engagements
"🦉 Facebook post claimed: Buying weight loss drugs just got easier. No prescription No problem. Violates Germanys HWG XX which restricts direct-to-consumer drug ads to certified medical personnel. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 16:24:05 UTC 4964 followers, XX engagements
"🦉 XXX X% final HbA1c in DD vs. XXX XXX% in nonDD (p=0.01). Yet HbA1c: XXX XXX% vs. XXX XXX% (p=0.8) baseline difference not treatment attenuation. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:18:22 UTC 4954 followers, XXX engagements
"Sanofis New RSV Vaccine Study: What Investors Need to Know $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:12:20 UTC 4966 followers, XXX engagements
"💼GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GLP1R" @AponiaAnalytics on X 2025-07-17 17:48:59 UTC 4962 followers, XXX engagements
"Emcure Pharmaceuticals Partners with Sanofi India to Distribute Amaryl and Cetapin for Diabetes Management $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:08:14 UTC 4966 followers, XXX engagements
"$BDPT $LWLG $NWBO $GTCH $FNMA $NB $ELTP $RDGL $HMBL $COOP 🌐" @AponiaAnalytics on X 2025-07-16 19:17:35 UTC 4967 followers, 1380 engagements
"$NVCR $SNDX $DCTH $AUTL $GERN $DAWN $IMCR $XBI 🌐" @AponiaAnalytics on X 2025-07-19 19:04:22 UTC 4955 followers, XXX engagements
"🦉 Energy metabolism shift: GLP-1 agonists promote lipid over carb utilization. Preserves muscle glycogen. Exendin-4 induces mitochondrial biogenesis in muscle. AMPK stability vital. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 19:34:14 UTC 4954 followers, XXX engagements
"🦉 In the SELECT trial weekly semaglutide reduced non-fatal MI in patients with ASCVD but no diabetes. In contrast trials like EXSCEL and ELIXA showed no MI reduction in broader T2DM populations. #GLP1 #diabetes $NVO $LLY $AZN $SNY $VKTX $GSK $PFE" @AponiaAnalytics on X 2025-07-20 21:26:34 UTC 4954 followers, XXX engagements
"Doctor issues severe warning to Ozempic users as hundreds make worrying diet admission $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:08:37 UTC 4966 followers, XXX engagements
"💼GLP-1 Receptor Agonists: Encouraging Signals for Treating Alcohol Use Disorder $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 20:55:37 UTC 4965 followers, XXX engagements
"💼Optic Neuropathy and Other Hidden Ocular Risks of GLP-1 RA Weight Loss Drugs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-14 18:10:35 UTC 4963 followers, XXX engagements
"💼 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-17 18:24:11 UTC 4965 followers, XXX engagements
"🦉 GLP-1Rs in synovium and cartilage regulate TNF- IL-6 IL-1. Liraglutide and dulaglutide reduced MMP-3/13 ADAMTS4/5 and ROS. Results: decreased chondrocyte apoptosis and joint degradation. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 20:39:37 UTC 4954 followers, XXX engagements
"💼Ita Asset Management and KKR form Exclusive Strategic Partnership in Brazil to Broaden Private Market Investment Opportunities in Latin Americas Largest Market #investment #Brazil $KKR $ITUB" @AponiaAnalytics on X 2025-07-09 12:52:17 UTC 4962 followers, XXX engagements
"$NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $GOOGL $AMZN $NVDA $SOFI $TSLA $AMD $PINS $AAPL $NU $COIN $RDDT $TTD $NVTS $OSCR $LULU $NKETop $VKTX $DAWN $TMDX $AXSM $TRVI $TGTX $MREO $CRVS $MDGL $LLY $OCUL $HIMS $PDSB $LRMR 🌐" @AponiaAnalytics on X 2025-07-08 14:28:43 UTC 4965 followers, XXX engagements
"Denmarks EIFO and Novo Nordisk Foundation acquire worlds most powerful quantum computer from Microsoft $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:08:54 UTC 4965 followers, XXX engagements
"$BBIO $SLDB $GPCR $UNH $IOVA $SRPT $CYTK $DRUG $MDNAF $NKTR 🌐" @AponiaAnalytics on X 2025-07-08 14:29:07 UTC 4962 followers, 2277 engagements
"💼Why are we still in need for novel anti-obesity medications $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-17 16:13:40 UTC 4967 followers, XXX engagements
"🦉 GLP-1 increases hepatic glycogen even in absence of insulin via PI3K-AKT signaling. DCA and GRb also trigger this independently highlighting a non-insulin glycogenic route. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:35:43 UTC 4954 followers, XXX engagements
"💼Health Rounds: GLP-1 obesity drugs may boost low testosterone $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 17:02:01 UTC 4954 followers, XXX engagements
"🦉 Combined metabolic response5% weight loss plus X% HbA1c reductionwas reached by XXXX% at X months and XXXX% at XX months. Most effective in women with baseline HbA1c X% and BMI XX. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 18:02:17 UTC 4962 followers, XX engagements
"🦉 In X RCTs (n=1872) with type X diabetes patients once-weekly semaglutide XXX mg led to a mean weight reduction of XXXX% (95% CI: XXXX to 5.69) vs placebo. No heterogeneity (I = 0%). #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 17:16:40 UTC 4964 followers, XX engagements
"$KURA $RPTX $TCRX $IOVA $ACRV $NUVB $RCKT $IDYA $DCTH $RYTM $TARS $ARQT $ASND 🌐" @AponiaAnalytics on X 2025-07-03 22:54:05 UTC 4965 followers, XXX engagements
"🦉 Hypertension prevalence: DD XXXX% vs. nonDD XX% (p=0.001). Dyslipidemia: XXXX% vs. XXXX% (p=0.04). No differencesretinopathy macrovascular disease hypoglycemic admissions. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI" @AponiaAnalytics on X 2025-07-20 19:20:46 UTC 4954 followers, XXX engagements
"Glucagon-like Peptide-1 Receptor Agonist Therapy Is Associated With Fewer Medical Complications After Carpal Tunnel Release in Diabetic Patients $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:57:09 UTC 4963 followers, XXX engagements
"Health Rounds: GLP-1 obesity drugs may boost low testosterone $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:57:51 UTC 4965 followers, XXX engagements
"💼The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart Disease $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #cardiology #diabetes" @AponiaAnalytics on X 2025-07-13 19:21:19 UTC 4962 followers, XXX engagements
"💼Impact of Sleeping Habits on the Weight Loss Effect of Oral Glucagon-Like Peptide-1 Receptor Agonists Among Obese Patients: An Observational Study in Japan $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #sleep #obesity #Japan" @AponiaAnalytics on X 2025-07-13 16:39:09 UTC 4965 followers, XXX engagements
"MediPharm Labs Closes $XXX Million Sale of Hope BC $LABS $MEDIF $ROMJ $ROMJF $YOLO" @AponiaAnalytics on X 2025-06-05 13:04:36 UTC 4960 followers, XX engagements
"$NKTR $CRVS Conjunctivitis has emerged as a persistent adverse effect tied specifically to IL-4/IL-13 pathway inhibition in atopic dermatitis (AtD) biologics like Dupixent and Ebglyss. New evidence links this to IL-4RA expression on conjunctival goblet cellscreating an inherent ocular vulnerability in this mechanism. This opens a differentiated safety windowand possibly a major market advantagefor $NKTR (Rezpeg) and $CRVS (Soquelitinib). Both use novel mechanisms (Treg proliferation and ITK inhibition respectively) and have shown zero conjunctivitis events across XXX patients combined. If" @AponiaAnalytics on X 2025-07-08 13:41:18 UTC 4965 followers, 1795 engagements
"Hims & Hers Brass Face Suit Over 'Knockoff' Wegovy Sales $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:52:41 UTC 4965 followers, XXX engagements
"🦉 Semaglutide showed the lowest dropout rate due to side effects and fewer severe GI issues than liraglutide despite nausea remaining frequent in early use. Tolerability remains its comparative edge. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 15:04:41 UTC 4963 followers, XXX engagements
"$LYFT $PROK $ZVSA $BTCS $NDRA $LSB $SRFM $BSLK $RLYB $ITP $SQNS $SPY 🌐" @AponiaAnalytics on X 2025-07-08 19:19:38 UTC 4952 followers, XXX engagements
"🦉 Brown adipose tissue (BAT) immune-regulated. Neuronal GLP-1R deletion energy expenditure UCP1. iNKT cells and monocyte IL-6 activation mediate BAT thermogenesis via GLP-1. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 19:32:42 UTC 4954 followers, XXX engagements
"🦉 Dropout rate in women: 18.2%. Main reasonsGI intolerance (9.8%) and lack of follow-up (4.4%). No severe adverse events reported; discontinuation not linked to any baseline factor. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 18:04:49 UTC 4962 followers, XXX engagements
"Lillys Zepbound faces a potential weight-loss rivalmade by a Chinese biotech $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:51:13 UTC 4960 followers, XXX engagements
"🦉 Among those with metabolic liver disease and diabetes GLP-1 agonists reduced cirrhosis its complications and mortality versus DPP-4 inhibitors. Alcohol-related liver risk may be mitigated. #GLP1 #diabetes $NVO $LLY $AZN $SNY $VKTX $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 21:10:49 UTC 4954 followers, XXX engagements
"💼Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-17 18:20:08 UTC 4963 followers, XXX engagements
"🦉 Sipes prescribed Zepbound in Sep 2024 lost 60+ lbs in X months. Symptoms improved: regular periods reduced cysts joint pain cravings. GLP-1s may modify inflammatory and hormonal drivers of PCOS. #Zepbound #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHB" @AponiaAnalytics on X 2025-07-20 16:01:08 UTC 4962 followers, XX engagements
"💼GLP-1 and the Neurobiology of Eating Control: Recent Advances $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-17 18:13:40 UTC 4962 followers, XXX engagements
"$JUSHF $MSOS $YOLO $PSIL $CXXIF $GLASF 🌐" @AponiaAnalytics on X 2025-07-11 13:20:40 UTC 4964 followers, XXX engagements
"FDA staff express uncertainty regarding usefulness dosing of Sanofi's diabetes therapy iGlarLixi $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:03:22 UTC 4962 followers, XXX engagements
"Viking Therapeutics: What's Next After GLP-1 Hype Dies Down And Competition Intensifies $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:06:44 UTC 4962 followers, XXX engagements
"FDA grants fast track designation to Sanofis SAR446597 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:41:26 UTC 4964 followers, XXX engagements
"Novo Nordisk Foundation and EIFO buy world's most powerful quantum computer $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:43:47 UTC 4960 followers, XXX engagements
"🦉 Dr. Cree's trial spans ages 1235 with PCOS and obesity. It compares semaglutide effects on those with and without Metformin measuring weight hormones ovulation and age-related response over XX months. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 16:02:28 UTC 4962 followers, XX engagements
"Hims & Hers plans Canada expansion to time patent cliff for Novos Weogvy $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:02:48 UTC 4962 followers, XXX engagements
"Novo Nordisk to buy worlds most powerful quantum computer from Microsoft $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:41:05 UTC 4965 followers, XXX engagements
"B.C. limits sale of X more diabetes drugs used for weight loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:06:51 UTC 4961 followers, XXX engagements
"Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:47:15 UTC 4963 followers, XXX engagements
"🦉 New dual agonists like tirzepatide intensify appetite suppression but side effects like muscle loss and facial fat wasting complicate long-term use without new mitigation strategies. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-17 18:20:09 UTC 4965 followers, XXX engagements
"Union health plan sues Optum Rx for covering costly weight loss drugs including Wegovy $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:11:26 UTC 4966 followers, XXX engagements
"Thermo Fisher buys Sanofi factory; Amphastar Pharma quadruples HQ capacity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:38:57 UTC 4960 followers, XXX engagements
"💼Shifting obesity treatment paradigms: Trends of glucagon-like peptide-1 receptor agonists and bariatric surgery in the United States $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-18 14:54:10 UTC 4954 followers, XXX engagements
"🦉 1200000 likes on TikTok vs. 137807 on YouTube: Most-liked posts lacked drug mechanism indications or cost data. Popularity accuracy. Visual appeal outweighs pharmacological content. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 16:22:06 UTC 4964 followers, XX engagements
"🦉 Retrospective studies: Semaglutide lowered 2-year rotator cuff retear rate and reduced infection risk post-arthroscopic repair in T2DM. Also reduced readmissions after spinal fusion. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 20:42:48 UTC 4954 followers, XXX engagements
"💼Advances in GLP-1 receptor agonists for pain treatment and their future potential $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 21:47:16 UTC 4954 followers, XXX engagements
"🦉 Amgens maridebart cafraglutide cut weight by up to XX% in patients without diabetes and XX% in those with T2D outperforming placebo by X to 13x. No plateau by week XX suggests ongoing efficacy. $AMGN $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GIP #Obesity" @AponiaAnalytics on X 2025-07-16 22:35:54 UTC 4955 followers, XXX engagements
"Doctor issues urgent advice as hundreds of weight-loss jab users share concerns over diet $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:55:19 UTC 4960 followers, XXX engagements
"🦉 Swedish-Danish registry study: GLP-1 agonists not linked to increased risk of suicide self-harm depression or anxiety. Suggests neuropsychiatric safety in AUD-relevant populations. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 21:10:14 UTC 4954 followers, XXX engagements
"🦉 ADA 2025: GLP-1 RAs (SGLT2i) recommended to prevent MACE in T2DM with ASCVDirrespective of HbA1c or metformin. Highest A-grade evidence. ESC ACC/AHA guidelines also aligned for chronic coronary disease. #GLP1 #ASCVD $NVO $LLY $AZN $SNY $VKTX $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 21:32:53 UTC 4954 followers, XXX engagements
"🦉 The DNA-based biosensor tracked phenylalanine shifts tied to protein intake and muscle degradation. Tested up to 1500 M/L it stayed stable over X days offering potential for clinical use in GLP-1 and aging care. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 18:55:41 UTC 4965 followers, XXX engagements
"🦉 Benefits scale with treatment intensity: higher GLP-1 doses and longer use produce stronger outcomes. Semaglutide ranked best for both weight loss and cardioprotection among GLP-1 drugs. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 19:43:38 UTC 4962 followers, XXX engagements
"$SMCE $HMBL $DTREF $GTCH $SAPX $IGPK $ENTA $AFFU $TWOH $RITE $ADHC $FITY $CYBL $GTCH $NWBO $FNMA $ELTP $AVXL $PSRU $COOP $AFFU $CGAC $PSWW 🌐" @AponiaAnalytics on X 2025-07-18 17:21:31 UTC 4965 followers, XX engagements
"Targeted in vivo gene integration of a secretion-enabled GLP-1 receptor agonist reverses diet-induced non-genetic obesity and pre-diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:09:15 UTC 4965 followers, XXX engagements
"🦉 Among 3842 non-diabetic participants in X RCTs the same semaglutide dose achieved a mean weight loss of XXXXX% (95% CI: XXXXX to 10.19). Heterogeneity was moderate (I = 63.3%). #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 17:16:58 UTC 4965 followers, XXX engagements
"💼What are drugs like Ozempic doing to the brains of people that binge eat $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 16:57:23 UTC 4954 followers, XXX engagements
"$NWBO $RDAR $HPNN $TPTW $HMBL $CBDD $GRLT $HCMC $AITX $DPLS $FNMA ✍" @AponiaAnalytics on X 2025-07-16 17:28:16 UTC 4964 followers, XXX engagements
"💼Ozempic and Wegovy may cut dementia risk by XX% and manage d. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #ozempic #wegovy" @AponiaAnalytics on X 2025-07-20 16:07:05 UTC 4954 followers, XXX engagements
"🦉 With FDA removing semaglutide and tirzepatide from its shortage list 503A pharmacies now face stricter compounding rules tied to essentially a copy standards and specific clinical difference justifications. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 14:45:54 UTC 4963 followers, XXX engagements
"Press Release: Sanofi announces extension of Blueprint tender offer - 17.07.25 - News $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:50:57 UTC 4965 followers, XXX engagements
"🦉 Waist circumference: DD group XXXXX XXXX cm vs. XXXXX XXX cm (p=0.001). At followup persisted: XXX XXX cm vs. XXX XXX cm (p=0.001). #obesity #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 19:16:21 UTC 4964 followers, XX engagements
"🦉 X mmHg SBP reduction with tirzepatide in SURMOUNT-1 paired with XX% weight loss at XX mg dose. Far surpasses BP and weight changes in GLP-1 RA trials likely from dual GIPR/GLP-1 mechanism. #Tirzepatide #obesity $NVO $LLY $AZN $SNY $VKTX $GSK $PFE" @AponiaAnalytics on X 2025-07-20 21:30:51 UTC 4954 followers, XXX engagements
"$NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-17 18:22:30 UTC 4965 followers, XXX engagements
"In this cross-sectional study we collected posts and comments from the X most active GLP-1 medicationrelated forums on a social media website (Reddit; Advance Publications) in July 2024. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 15:00:25 UTC 4965 followers, XXX engagements
"🦉 XXXX% of Instagram before/after posts were likely AI-generated (DeepFake-o-meter). TikToks average was 51.6%. High AI use may distort expectations and fuel unregulated semaglutide use. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 16:23:09 UTC 4965 followers, XX engagements
"🦉 Persistence rate in women using oral semaglutide was XXXX% over one year. Despite GI intolerance in nearly X in XX overall adherence was high and similar to previous GLP-1 RA studies. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 18:07:34 UTC 4962 followers, XXX engagements
"🦉 Dopaminergic modulation. GLP-1 agonists suppress mesolimbic dopamine. May reduce reward-seeking behavior but raise risk of depression in DRD2 Taq1A polymorphism carriers. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:34:55 UTC 4954 followers, XXX engagements
"🦉 The therapy used lipid nanoparticles to deliver CRISPR components achieving X% knock-in at the albumin gene with no off-target edits. A second dose doubled Exendin-4 output. Safety markers like liver enzymes stayed normal. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity #diabetes" @AponiaAnalytics on X 2025-07-13 19:12:12 UTC 4956 followers, XXX engagements
"🦉 In just six weeks tirzepatide slashed calorie intake by 72%without participants trying to restrict food. Unlike semaglutide or liraglutide it blunted hunger by rewiring activity in key brain regions tied to cravings. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide" @AponiaAnalytics on X 2025-07-18 22:17:52 UTC 4968 followers, XXX engagements
"🦉 GLP-1 drugs drive weight loss mainly by suppressing appetite not by boosting energy use. But once stopped most users regain up to XX% of the lost weightdespite diet and exercise. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-17 18:20:09 UTC 4965 followers, XXX engagements
"Viking Therapeutics (VKTX) Soars XXX% on Looming Weight Loss Drug Trial Results $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:06:01 UTC 4962 followers, XXX engagements
"🦉 STEP X (DM): XXX% weight loss. STEP X and X (non-DM): 15%. Meta-analysis confirms the trenddiabetes dampens semaglutide efficacy in weight loss. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 17:20:12 UTC 4964 followers, XX engagements
"🦉 Odds ratios in DD group: hypertension OR=7.44 (95% CI 1.6134.46); nephropathy OR=5.14 (1.6216.35); female sex OR=2.77 (1.266.06). #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:19:41 UTC 4954 followers, XXX engagements
"🦉 G2 improved HDL-C significantly: +0.27 mmol/L (p = 0.001) vs. G1s +0.004 mmol/L (p = 0.049). LDL-C reduction also greater in G2 (0.17 mmol/L; p = 0.004). Suggests stronger lipid modulation. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 19:52:11 UTC 4963 followers, XX engagements
"🦉 Blood pressure lowered within X weeks of liraglutide therapy suggesting vascular effects beyond weight loss. DURATION-1 showed XXX mmHg SBP drop with exenatide X mg/week; other trials reported less. #GLP1 #bloodpressure $NVO $LLY $AZN $SNY $VKTX" @AponiaAnalytics on X 2025-07-20 21:29:59 UTC 4954 followers, XXX engagements
"💼Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 20:53:13 UTC 4962 followers, XXX engagements
"🦉 Eli Lilly has launched a double-blind Phase X trial of tirzepatide in overweight adults with type X diabetes a group with few targeted therapies. The drug is being tested for glycemic control and weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide #GLP1" @AponiaAnalytics on X 2025-07-18 22:06:47 UTC 4968 followers, XXX engagements
"💼Case-Based Review of Breast Imaging Changes Associated With GLP-1 Agonists $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 21:00:52 UTC 4965 followers, XXX engagements
"Novel glucose-lowering agents that benefit diabetic foot: icing on the cake $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:47:55 UTC 4954 followers, XXX engagements
"🦉 Sulfonylurea and insulin use in DM may blunt weight reduction from GLP-1 agonists. Insulin promotes fat storage opposing the catabolic effects of semaglutide. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 17:20:58 UTC 4954 followers, XXX engagements
"🦉 One hormone three effectsstimulates insulin (when glucose is high) suppresses glucagon and delays gastric emptying. Together these regulate post-meal glucose and appetite with high precision. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 15:29:23 UTC 4962 followers, XX engagements
"🦉 A new trial found semaglutide helped people with type X diabetes lose fat and spend more time in healthy blood sugar rangesomething older GLP-1 drugs never really delivered on. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1" @AponiaAnalytics on X 2025-07-18 19:03:40 UTC 4967 followers, XXX engagements
"💼GLP-1 and GIP Combination Shows Promise for Weight Loss Cardiometabolic Improvement in Obesity $AMGN $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GIP #Obesity" @AponiaAnalytics on X 2025-07-16 22:35:53 UTC 4967 followers, XXX engagements
"🦉 GLP-1s may benefit PCOS by lowering insulin. Lower insulin reduces ovarian androgen outputcutting testosterone and improving symptoms like acne hirsutism and cycle irregularity. Mechanism is indirect but consistent. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 15:59:26 UTC 4963 followers, XX engagements
"🦉 STEP-HFpEF: semaglutide improved weight 6MWD and QoL in obese HFpEF patients. HF events decreased. Although underpowered for outcomes results support larger trials. Weight loss may be the driver. #Semaglutide #HFpEF $NVO $LLY $AZN $SNY $VKTX $GSK" @AponiaAnalytics on X 2025-07-20 21:31:59 UTC 4954 followers, XXX engagements
"💼Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors #GLP1 #cardiovascular" @AponiaAnalytics on X 2025-07-18 19:51:07 UTC 4967 followers, XX engagements
"🦉 FIGHT and LIVE trials: liraglutide failed to improve outcomes in HFrEF. LIVE reported more ventricular tachycardia and ischemiapossibly tied to increased heart rate a known GLP-1 RA side effect. #GLP1 #heartfailure $NVO $LLY $AZN $SNY $VKTX $GSK" @AponiaAnalytics on X 2025-07-20 21:28:57 UTC 4954 followers, XXX engagements
"Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:46:28 UTC 4960 followers, XXX engagements
"🦉 XX% of semaglutide users on social media took it for weight loss or PCOS not diabetes. Ozempic FDA-approved for T2D only was used off-label in almost all TikTok and Instagram content. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 16:18:05 UTC 4964 followers, XX engagements
"🦉 GLP-1 receptor agonists are emerging as multi-target tools in chronic respiratory disease reducing inflammation oxidative stress and bronchial remodeling through CNS and immune modulation. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1" @AponiaAnalytics on X 2025-07-17 19:45:04 UTC 4964 followers, XXX engagements
"🦉 In STEP trials semaglutide + lifestyle changes produced XX% average weight losspreviously only seen with bariatric surgery. Weekly injection and daily oral tablet formulations exist. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 15:28:58 UTC 4962 followers, XXX engagements
"🦉 Correlations: female sex + weight loss (r=0.2 p=0.02); insulin use weight loss (r=0.347 p0.001); alcohol XX g/day weight loss (r=0.229 p=0.01). #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:18:51 UTC 4954 followers, XXX engagements
"🦉 Benefits even extend to osteoporosis cardiovascular damage and PCOS. Some effects come through GLP-1R-independent pathways making these drugs surprisingly versatile across diseases. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-17 17:36:44 UTC 4960 followers, XXX engagements
"$NCNA $HCTI $SPZI $PNPN $CNRC $SAGMF $CFTN $ADHC $TWOH $CBRA $EHVVF ✍" @AponiaAnalytics on X 2025-07-16 19:25:36 UTC 4962 followers, XXX engagements
"🦉 Analysis of XX RCTs covering 48891 patients shows GLP-1 therapy cuts MACE risk by XX% lowers weight by XXX kg and reduces systolic BP by XXX mmHg. All without needing a diabetes diagnosis. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 19:43:37 UTC 4964 followers, XXX engagements
"🦉 Investigational scope widening: GLP-1 RAs show promise in neurodegenerative diseases NAFLD PCOS and even addictionvia anti-inflammatory and neuroprotective mechanisms. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 15:33:01 UTC 4962 followers, XXX engagements
"AbbVies Skyrizi Novos Wegovy duke it out in Q2 TV ad spending totals $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:56:59 UTC 4964 followers, XXX engagements
"🦉 XX% and XX% lower risk of AUD-related hospitalization with semaglutide and liraglutide respectively per Swedish population-wide analysis. Approved AUD meds reduced this risk by only 2%. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 21:09:25 UTC 4954 followers, XXX engagements
"🦉 X XXX% weight loss in DD vs. XXX XXX% in nonDD (p=0.4). BMI weight waist reduction showed no significant group difference. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:17:37 UTC 4954 followers, XXX engagements
"🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists In SELECT (Kushner 2025) semaglutide XXX mg reduced serious adverse events in obese CVD patients. GI side effects caused higher discontinuation. #SELECT #safety $NVO $SNY" @AponiaAnalytics on X 2025-07-20 14:20:56 UTC 4965 followers, XX engagements
"🦉 306K Instagram posts under #ozempic; yet only X% of creators referenced type X diabetes. Off-label demand has overwhelmed supplydespite Ozempic's limited approval scope and contraindications. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY" @AponiaAnalytics on X 2025-07-20 16:27:05 UTC 4962 followers, XXX engagements
"🦉 Despite lack of VAT difference liraglutide reactivated GLUT4 MAPK PPAR- reduced TGF- and lowered TNF- IL-6 IL-1. Mechanisms may explain stronger metabolic benefit in T2D. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 19:56:22 UTC 4954 followers, XXX engagements
"$capc $hmbl $gtch $atvk $qind $ipsi $rdar $psww $psru $rkar $hysr $shmp $nwbo $smce $hcti 🌐" @AponiaAnalytics on X 2025-07-18 17:28:44 UTC 4954 followers, 2197 engagements
"Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:57:34 UTC 4960 followers, XXX engagements
"Ozempic Wegovy: X factors may influence weight loss results $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 22:52:38 UTC 4962 followers, XXX engagements
"Researchers Explore Potential of Ozempic in Addressing Addiction Through Brain Reward Pathways $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:48:10 UTC 4965 followers, XXX engagements
"🦉 With the study launched in late June early metabolic data could shape investor expectations. If absorption and excretion align the asset may gain strategic weight in Eli Lillys early pipeline. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 00:39:19 UTC 4965 followers, XXX engagements
"🦉 Karim began Mounjaro via Noom in April 2024. After years of symptoms including a 5-month-long period treatment led to weight loss and symptom relief. Later used compounded version amid access barriers. #Mounjaro #PCOS $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 16:01:34 UTC 4965 followers, XX engagements
"🦉 12-week oral semaglutide study: XXXX% energy intake vs placebo stronger satiety appetite control. Effects due to increased PYY decreased postprandial GLP-1 and cravings. #Semaglutide #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 19:36:06 UTC 4954 followers, XXX engagements
"🦉 GLP-1-based drugs calm overactive immune cells lowering inflammation in the gut fat liver and blood vessels. But their effects depend on sex time of day and gut bacteriafactors that may explain why side effects and results vary so much. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GLP1R" @AponiaAnalytics on X 2025-07-17 17:49:00 UTC 4965 followers, XXX engagements
"Fake weight loss drugs spark alarm: Warning sent to FDA FTC over counterfeit GLP-1s $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:07:42 UTC 4966 followers, XXX engagements
"💼This Obesity Drug Cuts Calorie Intake by XX% Without Dieting $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide" @AponiaAnalytics on X 2025-07-18 22:17:51 UTC 4954 followers, XXX engagements
"💼New investigation launched after health experts find potentially fatal side effect of taking weight loss drugs According to UK reports there have been approximately XX deaths linked to this condition thanks to the GLP1 drugs. $NVO $LLY $AZN $SNY $GSK" @AponiaAnalytics on X 2025-07-20 16:32:47 UTC 4954 followers, XX engagements
"🦉 XXX T2DM patients treated with GLP1 RAs X months: XXXX% (53/115) had documented depressive disorder (DD) via clinical diagnosis chronic antidepressants or BDI XX. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:15:09 UTC 4962 followers, XXX engagements
"🦉 XXX mg/day liraglutide over X months: G2 (obesity + T2D) had greater A1c% reduction (1.15%; p = 0.001) vs. G1 (obesity + prediabetes) (0.5%; p = 0.000). Indicates enhanced glycemic response in T2D. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE" @AponiaAnalytics on X 2025-07-20 19:50:20 UTC 4954 followers, XX engagements
"💼Eli Lillys New Study on Tirzepatide: Potential Game-Changer for Type X Diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #tirzepatide #GLP1" @AponiaAnalytics on X 2025-07-18 22:06:46 UTC 4964 followers, XXX engagements
"🦉 Less than X% of U.S. individuals with AUD use medications despite FDA approval. GLP-1RA usealready XX% of adults as of 2024may create off-label opportunities to fill this treatment gap. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 21:11:36 UTC 4954 followers, XXX engagements
"🦉 In obese mice: GLP-1RA upregulated muscle oxidative fibers glycogen stores and mitochondrial activity. In humans muscle fatty infiltration decreased despite modest SMI reduction. #GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 20:39:05 UTC 4956 followers, XXX engagements
"🦉 Despite record-breaking weight loss results current drugs face real-world barriers: high drop-out rates lean mass loss and fast weight regain after stopping. Their long-term utility remains fragile. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-17 16:13:41 UTC 4956 followers, XXX engagements
"🦉 LEADER trial: liraglutide reduced major cardiovascular events in type X diabetes patients. Heart protectionnow a confirmed clinical endpoint for several GLP-1 receptor agonists. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 15:31:52 UTC 4954 followers, XXX engagements
"🦉 Despite anecdotal benefit GLP-1s are not FDA-approved for PCOS. No endpoints exist for PCOS trials slowing drugmaker interest. Insurance often wont cover off-label use leaving patients with $1000/month costs. #PCOS #insurance $NVO $LLY $AZN $SNY" @AponiaAnalytics on X 2025-07-20 16:03:32 UTC 4955 followers, XX engagements
"🦉 How to enhance natural GLP-1 output: 1) Prioritize protein fiber and healthy fats. 2) Regular cardio + resistance training. 3) Fermented foods. 4) Sleep X hrs. 5) Stress control. #GLP1 #weightloss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 15:34:07 UTC 4962 followers, XXX engagements
"💼Beyond Blood Sugar: A Scoping Review of GLP-1Receptor Agonists in Cardiovascular Care $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 21:48:57 UTC 4954 followers, XXX engagements
"🦉 Use of GLP-1 drugs like semaglutide skyrocketed XX times in just six years while weight-loss surgeries dropped 65%a trend that actually started before the drugs took off. Semaglutide is now the top choice. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-18 14:54:11 UTC 4966 followers, XXX engagements
"🦉 All patients showed clinical insulin resistance signs. Baseline visceral fat: G1 = XXXX (IQR 830); G2 = XXXX (IQR 920). Liraglutide improved insulin sensitivity in both. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 19:55:59 UTC 4954 followers, XXX engagements
"💼Study finds patients with interrupted GLP-1 access still achieve significant weight loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-18 19:10:46 UTC 4954 followers, XXX engagements
"Could weight loss drugs like Ozempic help combat addiction $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:48:37 UTC 4960 followers, XXX engagements
"Novel oral agents in anti-obesity pharmacotherapy: A narrative review $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-15 19:32:16 UTC 4963 followers, XXX engagements
"💼As a reporter I've covered all things GLP-1. Here's what I've learned. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 16:09:35 UTC 4954 followers, XXX engagements
"🦉 Baseline metabolic disparity: DD group had HbA1c XXX X% vs. XXX XXX% (p=0.01); fasting glucose XXXXX XXXX vs. XXXXX XXXX mg/dL (p=0.02); triglycerides XXXXX XXXXX vs. XXXXX XXXX mg/dL (p=0.001). #GLP1 #diabetes $NVO $LLY" @AponiaAnalytics on X 2025-07-20 19:15:50 UTC 4962 followers, XX engagements
"Sanofis Phase X Study on SAR444656: A Potential Game-Changer for Hidradenitis Suppurativa $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 22:58:44 UTC 4964 followers, XXX engagements
"🦉 Younger people are picking up GLP-1s faster but those under XX still lean more toward surgery. Only a tiny fraction who start GLP-1s end up getting surgery showing most stick to one route. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-18 14:54:11 UTC 4967 followers, XXX engagements
"🦉 Blunted response in DM group may stem from: 1) insulin resistance 2) chronic hyperinsulinemia 3) glycemic control reducing glycosuriadiminishing net energy loss. #diabetes #GLP1 $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-20 17:18:53 UTC 4964 followers, XXX engagements
"💼Targeted in vivo gene integration of a secretion-enabled GLP-1 receptor agonist reverses diet-induced non-genetic obesity and pre-diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 19:12:10 UTC 4954 followers, XXX engagements
"💼Comparative effectiveness of GLP-1 receptor agonists on glycaemic control body weight and lipid profile for type X diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes" @AponiaAnalytics on X 2025-07-19 15:25:40 UTC 4954 followers, XXX engagements
"🦉 Yessex matters in both effect and side effects. Women respond to GLP-1 analogs with stronger weight loss and food craving suppression amplified by estrogen's synergy with GLP-1 signaling. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #sex" @AponiaAnalytics on X 2025-07-17 16:23:06 UTC 4956 followers, XXX engagements
"$REGN $REPL $GSK $ASND $APLS $PTCT $REGN $KALV 🌐💲" @AponiaAnalytics on X 2025-07-03 14:59:41 UTC 4965 followers, XXX engagements
"$NBND $NWBO $AVXL $LWLG $EMED $AMRN $MVNT $COOP $HALO $SFWJ $BMXI $RDAR $VPLM $NLST $TGLO 🌐" @AponiaAnalytics on X 2025-07-17 21:28:54 UTC 4966 followers, XX engagements
"Obesity Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment DelveInsight $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:55:45 UTC 4965 followers, XXX engagements
"💼Sai Life Sciences exec: GLP-1 boom has exploded the peptide field as firm opens new center $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-16 22:40:43 UTC 4964 followers, XXX engagements
"GLP-1 drug akin to Ozempic showed no benefits for Parkinsons disease $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:07:02 UTC 4966 followers, XXX engagements
"🦉 Semaglutide must drop XX% and tirzepatide XX% to meet the $100K/QALY threshold. Current cost: $700$800/month. Even under optimal health gains both remain economically inefficient. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-14 18:02:01 UTC 4963 followers, XXX engagements
"🦉 Among 6392 patients in a weight-loss program XXXX% had GLP-1 treatment interruptionsyet still averaged XXXX% weight loss in a year. Even minimal exposure led to meaningful results. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-18 19:10:47 UTC 4968 followers, XXX engagements
"GLP1-RA and SGLT2-i: Implementation and Insulin Deescalation Strategies $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-12 23:05:44 UTC 4962 followers, XXX engagements
"💼Eli Lillys New Study on LY4065967: Key Insights for Investors $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 00:39:18 UTC 4963 followers, XXX engagements
"🦉 No between-group difference in VAT decrease with liraglutide but G2 improved glucose by XXXX mmol/L (p = 0.002) vs. XXXX mmol/L in G1 (p = 0.002). Consistent effect in T2D subgroup. #GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF" @AponiaAnalytics on X 2025-07-20 19:51:08 UTC 4964 followers, XX engagements
"💼Activation of GLP-1 receptors enhances the osteogenic differentiation process of STRO-1-positive BMSCs $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1" @AponiaAnalytics on X 2025-07-19 20:50:49 UTC 4954 followers, XXX engagements
"🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists Head-to-head trials directly comparing tirzepatide vs. semaglutide or exenatide remain absent. Agent selection remains data-limited. #GLP1 #trialgap $LLY $VKTX" @AponiaAnalytics on X 2025-07-20 14:25:28 UTC 4962 followers, XXX engagements
"SK bioscience Sanofi receive approval for pneumococcal vaccine trials in China - CHOSUNBIZ $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-18 16:05:40 UTC 4966 followers, XXX engagements
"Comparative effectiveness of combining antidiabetic medications to treat renal impairment in patients with type X diabetes mellitus $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:49:28 UTC 4963 followers, XXX engagements
"💼Head-to-head Study Shows Bariatric Surgery Superior to GLP-1 Drugs for Weight Loss $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #obesity" @AponiaAnalytics on X 2025-07-13 18:49:46 UTC 4964 followers, XXX engagements
"🦉 Next-gen therapies promise more than weight loss muscle preservation fewer side effects and lasting results via gene editing or combo molecules. Thats the gap today's meds still cant fill. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1" @AponiaAnalytics on X 2025-07-17 16:13:42 UTC 4956 followers, XXX engagements
"Emcure Pharma shares rise X% on deal to distribute Sanofi India's oral anti-diabetic products $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" @AponiaAnalytics on X 2025-07-17 16:51:33 UTC 4964 followers, XXX engagements
"🦉 At XX months XXXX% of women and XXXX% of men on oral semaglutide reached HbA1c 7%. No significant sex difference in glycaemic control dose persistence or side effect profile. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX" @AponiaAnalytics on X 2025-07-20 18:03:54 UTC 4954 followers, XXX engagements